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ABSTRACT
THE RELATIONSHIP OF PERSONAL CHARACTERISTICS,
BEHAVIORAL CAPABILITY, ENVIRONMENTAL FACTORS,
AND HYPERTENSION MEDICATION ADHERENCE IN AFRICAN
AMERICAN ADULTS WITH METABOLIC SYNDROME
by
KAREN ANDREA ARMSTRONG
Disparities in medication adherence (MA) associated with African American
(AA) adults may be related to a dynamic interplay between personal factors, behavioral
capability, and environmental factors. The purpose of the study was to examine this
relationship in AA adults with metabolic syndrome (MetS).
A cross-sectional, correlational analysis was conducted from baseline data from a
larger intervention study. Constructs from the Social Cognitive Theory were used to
predict MA. The sample of 91 AA adults with MetS was primarily middle-aged (age
range 45-70 years old; M 53, SD 6.3), female (79%), relatively well-educated, and
married.
Despite being on antihypertensive medications, 53% of the participants presented
with uncontrolled high blood pressure (≥130/90 mmHg). Although the vast majority
(95%) of the sample displayed adequate health literacy (HL), 30% of the sample was
non-adherent to their medication regimen.
A positive significant relationship was found between age and MA [χ2 (1, n = 90)
= 6.71, p = .01)]. Stress [χ2 (1, n = 90) = 6.28, p = .012)] and social support (SS) [χ2 (1,
n = 90) = 4.10, p = .04)] were the only significant relationships among environmental
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factors, barriers and hypertension MA. Highly stressed AA adults were significantly
more likely to be non-adherent or had a 15% reduction in the odds of hypertension MA.
Similarly, adults with a low income were 5.8 times more likely to be non-adherent (OR
5.828, 95% CI, 1.014-33.493, p= .0482), while those with low SS had a 9% reduction in
the odds of MA; SS trended toward significance (OR.914. 95% CI .823-1.016, p =.09).
With increasing age, AA adults were more likely to be non-adherent (OR 1.12, 95% CI
1.028-1.220, p =.0096).
Most of the participants reported a high degree of autonomy, satisfaction with
their health care climate, and the availability of SS. Although increasing age, adequate
SS, high stress, and adequate HL appeared to influence MA in AA adults with MetS, the
research questions were only partially answered. Further investigation of the
relationships and potential mediating pathways between personal characteristics,
environmental factors, behavioral capability and hypertension MA in AA adults with
MetS is needed.

INDEX WORDS: Medication Adherence, Health Literacy, Stress, Depression, Social
Support, Health Care Climate, and Medication Non-adherence
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Chapter I
Introduction
Medication adherence (MA) is important because many of the medications prescribed
are for chronic illnesses, such as metabolic syndrome (MetS). MetS is a cluster of
metabolic abnormalities that increases one’s susceptibility to risks of cardiovascular
disease (CVD) (Grundy, 2005) and like other chronic illnesses, if left uncontrolled can
lead to more serious outcomes. MetS is categorized by multiple risk factors which confer
greater risks for adverse clinical outcomes compared to a single factor (Chen et al., 2004;
Blank & Brunton, 2008). Given that multiple medications are prescribed for adults with
chronic illnesses (Murray et al., 2004a), medication adherence may be especially
challenging in this cohort of African American (AA) adults with MetS and its attendant
multiple risk factors.
Empiric evidence shows that African Americans frequently report multiple comorbidities, for which prescription medications are the primary therapeutic interventions
(Hilgers & Mann, 2008; Murray et al., 2004b). The finding is significant because AA
adults with chronic conditions frequently self-administer multiple prescription
medications without adequate supervision (Murray et al., 2004a). Sudano and Baker
(2001) found that a greater percent (73%) of AA adults report not following their
medication regimens compared to their White counterparts (64%). Therefore, medication
self-management in AA adults is an important health care issue because AA adults
frequently display low medication adherence (Sudano & Baker, 2001).
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Low medication adherence appears to be a patient-centered term; it illuminates the
extent to which an individual’s behavior deviates from medical or health advice
(Arozullah, Kim & Lee, 2006). It is well-documented that low medication adherence
contributes to additional health care costs due to frequent hospital re-admissions and
emergency department visits and a reduction in therapeutic value, and increases in the
risk for complications from chronic illnesses as a result of inappropriate dosing (Baker et
al., 2007; Frishman, 2007; Gazmararian, Baker, Parker, & Blazer, 2006; Osterberg &
Blaschke, 2005; Sudano & Baker, 2001).
Moreover, of considerable concern to nursing practice is that, although
medication adherence research spans over 30 years, very little of the existing research
addresses the topic from an African American perspective (Vlasnick, Aliotta, & DeLor,
2005). More research is needed since minorities, especially AA adults, continue to
experience significant health disparities (Anuurad, Chiem, Pearson, & Berglund, 2007;
Smedley, Stith, & Nelson, 2003) in cardiovascular disease and diabetes mellitus.
Although African American(s) (AA) have an increased risk for cardiovascular disease
(CVD) and diabetes, several studies have found that most AAs are unaware of their
increased risk for developing metabolic syndrome (MetS) (Grundy, Brewer, Cleeman,
Smith, & Lenfant, 2005). In fact, African Americans are at greatest risk (39%) for
hypertension when compared to Whites (29%), and Hispanics (28%) (Angell et al.,
2008). The increasing risk for hypertension in African Americans confers added risks for
cardiovascular disease (Annurad, Chiem, Pearson, & Berglund, 2007; Poon, Lal, Ford, &
Braun, 2009). Given the greater prevalence of hypertension-related morbidity and
mortality in African Americans, low hypertension medication adherence may be an even
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greater problem in this population because empiric evidence shows that low medication
adherence is a barrier to achieving proper blood pressure control (Bosworth et al., 2006;
Grundy, Brewer, Cleeman, Smith, & Lenfant, 2005). Low hypertension medication
adherence often results in uncontrolled high blood pressure, a critical component of MetS
which frequently leads to severe complications associated with CVD (Grundy, Brewer,
Cleeman, Smith, & Lenfant, 2008; Martins, Tareen, Ogedegbe, Pan, & Norris, 2008).
Purpose Statement
The purpose of this study was to examine medication adherence in AA adults with
MetS by determining the relationships among personal characteristics, behavioral
capability, and environmental factors. Personal characteristics included age, gender,
income, depression, and education, behavioral capability was conceptualized as health
literacy, while environmental factors included stress, social support, complexity of the
medication regimen, and quality of the therapeutic relationship between patient and
healthcare provider. The research suggests that a significant relationship exists among
medication adherence and key study variables in a variety of clinical populations, albeit
the exact nature of the relationship remains unclear. Therefore, more research was
warranted to describe more clearly suspected relationships in a cohort of AA adults with
MetS. It was expected that an investigation of key study variables would yield similar
findings to those unearthed in other study populations. In study populations such as
cancer, high blood pressure, renal populations, and diabetic populations, research has
provided evidence that key study variables influenced hypertension medication adherence
(Bosworth et al., 2006; Schillinger, Barton, Karter, Wang, & Adler, 2006).
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Empiric evidence suggests that medication non-adherence contributes to disparately
high rates of morbidity and mortality in African American adults (Angell et al., 2008;
Wright et al., 2008). The proposed study examined factors that may influence
hypertension medication-taking health behavior. Investigating factors that may influence
hypertension medication adherence in this population may lead to a greater understanding
of the way African American adults engage in self-management behavior, which in turn
may help explain the differences between African American and White adults in
morbidity and mortality.
The Social Cognitive Theory (SCT), a learning theoretical framework, provided the
justification for examining key study variables in a cohort of AA adults with MetS.
Study findings may help to develop interventions to promote positive outcomes in this
vulnerable population.
A secondary analysis was conducted, using baseline data that were collected as part
of a larger study, the Morehouse and Emory Team Up to Eliminate Cardiovascular
Health Disparities in AA (META Health) study (U.S. Department of Health and Human
Services [HHS], National Institutes of Health [NIH], National Heart, Lung, and Blood
Institute, [NHLBI] 2004-2010). A secondary analysis was used to illuminate the nature
of the relationship between medication adherence and personal characteristics, behavioral
capability, and environmental factors in a cohort of AA with MetS. Specifically, the
project illuminated several relationships by utilizing various analyses of existing data to
examine key study variables. The study produced a subtler picture of the state of the
science that is not present in the current existing literature. Based on the literature review
describing links among personal characteristics and environmental factors, the following
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research questions were posed:
Question 1: What is the relationship of personal factors (age, gender, income, depression,
co-morbidities, and education), behavioral capability (health literacy), and medication
adherence in AA adults with MetS?
Question 2: What is the relationship between environmental factors (stress and social
support), barriers (complexity of the medication regimen and non-therapeutic health care
climate), and medication adherence in AA adults with MetS?
Question 3: Will age, gender, income, education, health literacy, complexity of the
medication regimen, and quality of the therapeutic relationship explain a greater variance
in medication adherence over and above social support, stress, and depression in AA
adults with MetS?
Question 4: Will AA adults with adequate behavioral capability (health
literacy) report greater medication adherence than those with inadequate behavioral
capability (health literacy)?
Statement of the Problem
Framingham risk investigators analyzed their extensive database and found several
associations between MetS and CVD (Mosca et al., 2006). It is therefore very
problematic that although AA adults experience greater disease burden from CVD
compared to Whites and other minorities, several studies have found that most AA are
unaware of their increased risk for developing CVD (Chobanian et al., 2003; Grundy et
al., 2005). Moreover, no studies were found which addressed the awareness of risk
factors for MetS in AA adults who experience disparately negative health outcomes from
this syndrome. The finding is concerning because MetS is categorized by multiple risk
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factors which confer greater risks for adverse clinical outcomes compared to a single
factor (Blank & Brunton, 2008) and is a cluster of metabolic abnormalities that increases
one’s susceptibility to risks of CVD (Grundy, 2005).
Similarly, although the magnitude of the problem of low medication adherence is
well-documented (Gazmararian et al, 2006; Schillinger, Barton, Karter, Wang, & Adler,
2002), no studies were found that examined the potential factors which contribute to low
medication adherence in AA adults with MetS. Indeed, it is well-documented that AA
adults suffer a higher disease burden from CVD morbidity and mortality which is often
linked to low medication adherence. Moreover, very little of the current medication
adherence research explored the specificity of African American adults’ social contexts
or experiences that might explain their disparately low self-management behavior. Low
health behavior including low hypertension medication adherence has been shown to
exacerbate chronic conditions (Bosworth et al, 2006).
A large body of evidence reveals that AA adults have high rates of obesity, and in
overweight persons, MetS increases significantly to rates of over 50% (Grundy et al.,
2008). The evidence suggests that the disproportionate levels of obesity in AA translate
into a disproportionate burden of CVD morbidity and mortality (Lechleitner, 2008;
Rocha, 2008, Ryan, Farin, Abbasi, & Reaven, 2008). According to the Third National
Health and Nutrition Examination Survey (NHANES III) data, AA women have the
highest rate of abdominal obesity when compared to other ethnic groups (Brown, Vaidya,
Rogers et al., 2008; Park et al., 2003; Williams, Flack, Gavin, Schneider, & Hennekens,
2007). Notwithstanding, although extensive research has been conducted to examine the
relationships among personal characteristics and environmental factors, no study
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examined the mechanisms through which environmental factors, such as social support
and stress, interact with or mediate health literacy to predict hypertension medication
adherence in a cohort of AA adults with MetS. It is believed that increasing access to
care could improve healthcare outcomes for AA with MetS by early identification of
persons at risk for MetS and by targeting modifiable risk factors for medication nonadherence such as quality of social support, level of stress and depression, and health
literacy.
Background
Health Disparities
Nelson (2003) defined health disparities as racial or ethnic differences in the quality
of healthcare. Research suggests that much of the health disparity in diagnosis and
treatment has been linked to personal and environmental factors but findings are
inconclusive (Brietzke, 2007; Gazmararian et al., 2006). Similarly, Smedley (2003) and
colleagues found that health disparities are not necessarily due to access-related factors,
clinical needs, preferences, or appropriateness of intervention (Smedley, Stith, & Nelson,
2003). According to the National Center for Health Statistics (2002), life expectancy at
birth is 71.1 years for AA, and 77.1 years for Whites. AAs have the lowest self-rated
health status relative to Whites and Hispanics (Wright et al., 2008; Hilgers & Mann,
2008; Schoenthaler, Ogedegbe, & Allegrante, 2007). Also, African American adults
have the highest death rates of any of America’s racial and ethnic groups related to CVD
events (Centers for Disease Control and Prevention [CDC], National Vital Statistics
Report, 2006). In addition, several epidemiologic studies provide evidence that vascular
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disease and its cardiovascular complications increase morbidity and mortality in AA
versus their White counterparts (American Heart Association [AHA], 2007).
Health Disparities Related to MetS
MetS afflicts 50 million Americans or 25% of the adult population (Chen et al.,
2004; Grundy et al., 2008). Empiric evidence supports the existence of ethnicity-specific
differences in metabolic complications associated with obesity (Grundy et al., 2005). In
fact, among minority populations, the escalating incidence of obesity significantly
increases the risk for MetS by over 50% (Ford, 2006). In addition, the prevalence of
MetS increases with advancing age; 44% of adults over 50 years old have MetS (Ford,
2006; Grundy, 2005).
The age-adjusted prevalence of MetS is 32% of Mexican Americans, 24% of
Whites, and 22% of AA (Park et al., 2003). Although AA women seem to have a higher
(21%) than AA men (14%), this incidence is somewhat lower than that of White women
(23%) and Mexican American women (27%). Brown et al., 2008; Ford, 2006).
Paradoxically, although AA adults have lower rates of MetS than Whites or Mexican
Americans, their history of CVD puts them at greater risk for mortality from coronary
heart disease (CHD) and stroke (Chobanian et al., 2003; Grundy et al., 2008).
Personal and environmental factors that impact medication adherence and subsequent
use of the healthcare delivery system may be rooted in sociological underpinnings such
as cumulative disadvantage and multiple-jeopardy. These sociological underpinnings
will be briefly addressed.
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Cumulative Disadvantage
Dannefer (2003) defines cumulative disadvantage as a compounding of negative
circumstances where inadequate social capital confers major disadvantage for older
African American adults. African American adults have experienced a lifetime of
cumulative disadvantage from opportunity structures of education, social services, and
healthcare delivery (Smedley, Stith, & Nelson, 2003). A lifetime of discrimination and
poverty translates to an accumulation of disadvantages and poor health in later life
(Dannefer, 2003; Lee & Carrington, 2007; Stoller & Gibson, 2005). This cumulative
disadvantage results from a complex and dynamic interplay of macro-social and microsocial forces and is often reflected in disparities in the healthcare delivery system
(Kripalani et al., 2006; Toren, Kerzman, Koren, & Baron-Epel, 2005; Williams, 1998).
For example, negative emotions such as stress and anger may be caused by racial
discriminations and institutionalized racism in health care or in the workplace (Williams,
1998). Empiric evidence showed that stress was linked to depression which frequently
resulted in poor health care outcomes (Berkman et al., 2003; Cohen, Kamarck, &
Mermelstein, 1983).
Multiple-jeopardy
Research suggests that AA adults experience multiple-jeopardy because they fall in
more than one marginalized category (Dannefer, 2003). This multiple jeopardy
compounds the issue of vulnerability for AA adults. It is well-established that African
American adults have been disenfranchised and denied access to care because of limited
financial resources or inadequate social capital (Canto et al., 2000; Chisholm, 2004;
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Daumit, Hermann, Coresh, & Powe, 1999). One can readily appreciate the gravity of this
situation because African American middle-aged adults experience disparately high rates
of chronic illnesses coupled with severe co-morbidities (Cutler et al., 2008; Lagu et al.,
2009).
Healthcare Outcomes from Cumulative Disadvantage and Multiple-Jeopardy
Research substantiates the fact that cumulative disadvantage and multiple
jeopardy translate to psychological and physiological stress, which frequently lead to
negative healthcare outcomes (Berkman et al., 2003; Williams, 1998). Similarly, a
compounding of negative effects compromises health and frequently leads to stress and
depression which are significant correlates of medication adherence (Bane, Hughes, &
McElnay, 2006; Reynolds, et al., 2004). Stress precipitates and exacerbates depression
which affects about 20% of patients with coronary artery disease (CAD), and depression
is an important risk factor for death and acute coronary syndrome (ACS) (Berkman et al.,
2003; Steptoe et al., 2006). Cumulative disadvantage and multiple-jeopardy often
cascade into precipitating factors which contribute to burgeoning racial and ethnic
disparities. These disparities will now be addressed in greater detail.
Racial and Ethnic Disparities
The evidence of racial and ethnic disparities was almost always consistent across a
range of illnesses and healthcare services (Smedley, Stith, & Nelson, 2003). Although
the disparities seemed to be related to socio-economic differences, the differences often
disappeared when socio-economic factors were controlled for (Schillinger, Barton,
Karter, Wang, & Adler, 2006). Nevertheless, AA adults are less likely to have health
insurance than Whites (Nelson, 2003; US Census Bureau, 2001a), and AA adults are
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more likely to use publicly funded insurance such as Medicaid (The Henry, J. Kaiser
Family Foundation, 2000). African American adults frequently are not afforded the same
options or privileges in emergency procedures or CV interventions as their White
counterparts (Fiscella, Franks, Gold, & Clancy, 2000; Smedley, Stith, & Nelson, 2003).
When AA adults cannot afford quality health insurance, they are often relegated to
generalists not specialists, and this limits their access to care (Smedley, Stith, & Nelson,
2003). The emerging evidence suggests that racial and ethnic health disparities may be
linked to social and economic inequality, persistent racial and ethnic societal
discrimination, and subsequently differences in care from biases, prejudice, or
stereotyping (Nelson, 2003). The following statistics provide evidence of racial and
ethnic disparities which have been shown to contribute to a perpetuation of negative
healthcare outcomes for AA adults.
According to Census (2001b) data, 22.3% of AA over 65 years old fall below the
poverty line compared to 8.9% of White older adults. In urban areas, 43% of White older
adults over 65 years old and 27% of AA over 65 years old had greater than a 9th grade
education. Census data reveals that 37% of White older adults and 17% of African
American older adults obtained the General Education Diploma, while 27% of White
older adults compared to 8% of AA older adults actually graduated from high school.
Research suggests that most independent living older AA live in poverty (U.S. Census,
2001b). In addition, Census data showed that African American adults use far less social
and health services than their White counterparts. It is believed that these aforementioned personal and environmental factors, if left unrecognized and untreated in
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middle age, set the stage for a perpetuation of negative health care outcomes for AA
middle-aged adults in later life.
Significance of the Study for Nursing
Low medication adherence is a pervasive and complex problem and a hidden
epidemic in our society today (Balkrishnan et al., 2004; Haynes et al., 2005; PaascheOrlow, Parker, Gazmararian, Nielsen-Bohlman, et al., 2005). Nurses need to study this
problem of low MA to identify those AA adults who are at risk, and to intervene early to
promote positive healthcare outcomes in terms of morbidity and mortality. In fact, low
medication adherence is strongly influenced by the patient, the patient’s social support
system, the practice of health care providers, and the effectiveness of the healthcare
delivery systems (Berkman et al., 2003). Moreover, the evidence is consistent that
medication non-adherence is common among patients, regardless of the kind or the
severity of the disease (Paasche-Orlow et al., 2005; Peterson & McGhan, 2005;
Vermeire, Hearnshaw, Van Royen, & Denekens, 2001).
Although MA research spans several decades, a paucity of the research addresses
this topic in a cultural context (Vermiere et al., 2001). In fact, very little MA research
addresses the topic from an AA perspective. Sudano and Baker (2001) found that AA
adults (73%) were less likely to follow medication regimen when compared with their
White counterparts (64%). This is of great concern to healthcare providers given that AA
adults experience significantly higher incidences of chronic illnesses for which
medications constitute the most common therapeutic interventions (Haynes, McGibbon,
Kanani, Brouwers & Oliver, 2005; Vermiere, Hearnshaw, Van Royen & Denekens,
2001). For example, AA adults have a disproportionately higher incidence of
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hypertension and are twice as likely as older Whites to have diabetes (Powell, Hill, &
Clancy, 2007; Safeer & Keenan, 2005; Sarkar, Fisher, & Schillinger, 2006; Webster &
Perry, 2005).
Ramifications of Low Medication Adherence
An important component of low medication adherence is low self-management
behavior. Low self-management behavior is reflected in poor lifestyle choices that
contribute to the obesity epidemic. It is well-documented that obese persons incur
medical expenditures 40% higher than normal weight individuals (Curtis et al., 2007).
Obesity significantly contributes to uncontrolled high blood pressure. Empiric evidence
reveals that in African American adults, low hypertension medication adherence results
in uncontrolled blood pressure that accounts for nearly 8,000 preventable deaths per year
from cardiovascular events (Fiscella & Holt, 2008). Uncontrolled blood pressure has
economic consequences as well. For example, the escalating cost of hypertension
treatment approaches $70 billion (Rosamond et al., 2008). Similarly, uncontrolled blood
pressure has been shown to increase morbidity and mortality along with an increase in
health care expenditures of more than $100 billion a year (Frishman, 2007).
Low medication adherence is reflected in improper medication use that may result
in adverse effects such as dizziness, which frequently leads to falls. Fall-related injuries
among older people cost more than $20.2 billion annually (Centers for Disease Control
and Prevention [CDC], 2004). Falls also cause 90% of hip fractures, which cost $10
billion a year, and by 2020, the total annual cost of these injuries is expected to reach
$32.4 billion (CDC, 2004). Toren et al. (2008) provided evidence that low medication
adherence frequently leads to increased emergency department visits and re-
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hospitalizations because diseases got out of control. Similarly, Bosworth et al. (2006)
found that unscheduled surgeries are needed because of uncontrolled high blood pressure.
Finally, in a related study, low medication adherence was associated with disease
progression in a population with uncontrolled diabetes (Schillinger et al., 2006).
Negative Healthcare Outcomes
Voluminous literature documents the negative effects of medication nonadherence on AA adults’ medical outcomes (Chew, Bradley, & Boyko, 2004; Morris,
McLean, & Littenberg, 2006; Reynolds et al., 2004). In a cohort of renal transplant
patients, Nevins, Kruse, Skeans, and Thomas (2001) found that non-adherence to
medications led to acute transplant rejection and adverse outcomes. Similarly, Bosworth
et al. (2006), found that non-adherence with antihypertensive medication was a key factor
in the failure of antihypertensive therapy.
Moreover, empiric evidence reveals that even after controlling for similarities in
age, education, and occupational opportunities, African American adults still have higher
incidences of both mortality and morbidity compared to their White counterparts. It is
therefore not surprising that although CVD mortality has declined overall over the past
decade, AA continue to suffer a disproportionate burden of CVD disease mortality and
morbidity (Mensah, Mokdad, Ford, Greenlund, & Croft, 2005). In fact, although AA
adults have lower rates of MetS, their history of CVD puts them at greater risk for
mortality from CHD and stroke (Chobanian et al., 2003; Grundy et al., 2008).
The purpose of this study was to examine hypertension medication adherence in
AA adults with MetS by determining the relationships among personal characteristics,
behavioral capability, barriers, and environmental factors. The study purpose was
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accomplished by using a learning theoretical framework, the Social Cognitive Theory
(SCT) to guide this secondary analysis. Currently, SCT is one of the most influential and
widely used theoretical frameworks for studying health behaviors (Bosworth et al., 2006;
Gallant, 2003).
Theoretical Framework
According to Bandura (1986), the SCT is focused on the social influences that affect
learning (e.g. ethnicity, situation, and culture). It is well-established that the SCT is a
dynamic interplay of personal factors: a) cognition, affect and biological events; b)
behavioral capability, and c) environmental influences which create interactions that
result in behavior change (Bandura, 1977a, b). The SCT proposes that motivation to
perform a behavior is a strong predictor of performing that behavior (Vogt, Hall,
Hankins, & Marteau, 2009). Empirical evidence supports the existence of a relationship
among the SCT variables and MA health behavior (See Figure 1).
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Figure 1
Social Cognitive Theory to Predict Medication Adherence in AA with MetS
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SCT Overview
The SCT is a learning theory which is based on the premise that health behavior is
influenced by personal characteristics, environmental factors, self-efficacy, outcome
expectations, and behavioral capability (Bandura, 2008). In order to engage in
recommended health actions, the individual must be confident in their ability to perform
the desired behavior, and the environment must be supportive to facilitate and motivate
the behavior (Bandura, 1986).
The SCT has many objective empiric indicators that make it suitable for a
kaleidoscope of quantitative research in variety of clinical populations. The SCT can be
used to explain when and if people will perform health behaviors. Research supports the
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causal relationships between the predictors or determinants of the outcome behavior (e.g.,
Bosworth et al., 2006; Quinn, 2005).
This study focused on personal characteristics, environmental factors, and behavioral
capability which are major variables within the SCT. Based on the current review of the
literature, predictors for the SCT are consistently associated with healthcare outcomes in
a variety of clinical populations (Bosworth et al., 2006). The conceptualizations for SCT
model can be seen in Figure 1. Frequently, SCT is used as the framework for many
studies that address national health imperatives such as medication adherence and other
health behaviors (e.g. Quinn, 2005). SCT demonstrates usefulness in its applicability to
various patient populations such as adults with hypertension (HTN) (Bosworth, et al.,
2006) and cardiac rehabilitation (Lau-Walker, 2006). Moreover, SCT constructs are
tested frequently in medication self-management studies relating to blood pressure
control (Bosworth et al., 2006). The salience of empiric findings in diverse clinical
populations supports the pragmatic utility of the SCT in research with AA with MetS.
Major Concepts of SCT
The major concepts of the SCT are personal characteristics, environmental factors,
behavioral capability, barriers, self-efficacy (SE), and outcome expectations. The
behavioral outcome of interest in this study was medication adherence. Self-efficacy has
been found to be significantly associated with self-management behaviors in vulnerable
populations and SE was found to be one of the strongest predictors of medication
adherence in chronic illnesses (Gallant, 2003; Sarkar, Fisher, & Schillinger, 2006;
Schoenthaler & Ogedegbe, 2008). The literature showed that SE for medication-taking
improved self-management behavior based on health literacy levels (Lau-Walker, 2006;
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Schoenthaler et al., 2006). Similarly, Reynolds et al. (2004) found that participants
(n=980) with confidence in their abilities to take all their medications were more adherent
in their medication regimens. No gaps for medication-taking SE were identified in the
literature and the review of literature identified SE variables related to medication
adherence. There were no measures of medication-taking self-efficacy in the larger study
therefore SE was not tested in this secondary analysis.
Personal Factors
Personal factors include predisposing characteristics such as age, education, gender,
ethnicity, co-morbidities, and income. The personal characteristics of African American
adults determine the quantity and quality of personal resources that predict healthcare
access (Vaglio et al., 2004). Hendrix, Riehle, & Egan (2005) found that demographic
characteristics of patients such as age, gender, and ethnicity were associated with
significant differences in diagnostic testing, treatment, and control of disease components
in primary care. Age, education, income, depression, and co-morbidities may affect
medication adherence through factors such as general and health-specific cognitive
faculties (Murray et al., 2004a). Research suggests that age, income, and education are
significant predictors of health behavior (Davis at al., 2006; Gazmararian et al., 2006;
Murray et al., 2004b). Notably, Cavanaugh et al. (2008) found that in diabetic patients
(n=398) lower diabetes numeracy scores (ability to calculate blood sugar numbers) were
associated with older age, nonwhite race, fewer years of education, lower reported
income, lower literacy and general numeracy skills, lower perceived self-efficacy, and
worse self-management behaviors.
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Depression
Reynolds et al. (2004) provided evidence that depression was the strongest correlate
of medication non-adherence, and medications to treat chronic illnesses may intensify
depression. Moreover, it is well established that non-adherence subsequent to depression,
negatively influences individuals’ perceptions about health and quality of life (Bane,
Hughes, & McElnay, 2006; Schoenthaler, Ogedegbe, & Allegrante, 2007).
Behavioral Capability
Behavioral capability includes knowledge and skills necessary to perform a
behavior (Bandura, 1986). Knowledge and skills are key components of health literacy.
If adults have adequate knowledge, they may be more empowered to be active
participants in their health care decisions (Bandura, 1986). If adults are going to take
their medications, they need to know how to read and understand their health
instruction/information and how to take their medications correctly. Powell et al. (2007)
assessed the relationship between diabetes knowledge and readiness to take action and
found a positive expected relationship. It is well documented that simple mathematical
skills are important components of adequate health literacy which significantly predicts
positive health outcomes (Gazmararian et al., 2006). Research suggests that adequate
health literacy was a strong predictor of hypertension medication adherence in adults with
chronic illnesses such as high blood pressure and diabetes (Bosworth et al., 2006;
Gazmararian et al., 2006; Ngamvitroj & Kang 2007, Ogedegbe et al., 2004). Persons
with MetS must know what their blood pressure numbers and blood glucose levels mean.
It is expected that a similar relationship will be found in African American adults with
MetS.
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Environmental Factors
Environmental factors include external conditions such as home and community
composition and the level of social support derived from these sources (Schoenthaler,
Ogedegbe, & Allegrante, 2007; Murray, et al., 2004a). Within supportive environments,
middle-aged adults have opportunities to observe others achieve success, thus influencing
their likelihood of performing the same behaviors (Vaglio et al., 2004). When an adult
receives verbal encouragement from his family for taking his medications, this
accomplishment is more likely to re-occur. This motivation initiates a reciprocal
feedback loop for predicting positive health behaviors (Bandura, 1986).
Social Support
Haslam, Pakenam, and Smith (2006) defined social support (SS) as interpersonal
transactions that provide individuals with esteem, stress-related aid, and emotional
assistance. Social support has been assessed in numerous ways, including different types
and sources of social support. Types of social support include instrumental, emotional,
appraisal and informational (Whitfield & Wiggins, 2003). Sources of social support
include the social network of family, friends, coworkers, healthcare, church, and
community (Murray et al., 2004b). The critical component of the social network is the
level of satisfaction perceived by the recipient since social support has been linked to
positive health behavior (Gallant, 2003; Lee & Sharp, 2007). Chronic illnesses such as
diabetes and hypertension are a continual source of stress and social support is essential
to successful management of chronic illness (Gallant, 2003; Karslen, Idsoe, & Hanestad,
2004).
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Social Support and Chronic Illness Management
The effect of social support on individual agency, coping resources, and health
behaviors has been widely explored (Gallant, 2003; Lee & Sharp, 2007; Whitfield &
Wiggins, 2003). The literature shows the protective effects of social support for positive
healthcare outcomes and health behaviors (Lee & Sharpe, 2007; Collie et al., 2005).
Therefore, social support is an important factor in chronic illness management (Haslam et
al., 2006). In a recent study, Ogedegbe, Harrison, Robbins, Mancuso, & Allegrante
(2004) found that hypertensive AA’s (n=106) reported facilitators to medication
adherence were good social support and satisfaction with the patient-doctor relationships.
In several populations, it has been demonstrated that personal control frequently leads to
confidence in seeking medical information and complying with the medical regimen
(Collie et al., 2005; Lucove, Kaufman & James, 2008; Ngamvitroj & Kang, 2007).
Similarly, Reynolds et al. (2004) found that social support was an important explanatory
variable of high hypertension medication adherence. Adequate SS has been linked to
access to resources that help solve problems thus leading to confidence, personal control
of chronic illness, increased self-management behavior , and general control over life
(Lucove, Kaufman, & James, 2008). When stressors are experienced, having enough
social capital increases likelihood that stressors will be handled appropriately.
Stress
Empiric evidence suggests that environmental demands predispose individuals to
psychological stress (Berkman et al., 2003; Cohen, Kamarck, & Mermelstein, 1983;
Steptoe et al., 2006; Williams, 1998). In addition, the availability of healthcare
management resources impact stress, which frequently leads to negative health outcomes
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(Williams, 1998). Knox and colleagues (2008) posited that depression in AA is very
prevalent due to a convergence of societal and biological factors related to stress. Stress
may be caused by racial discriminations and institutionalized racism in healthcare or in
the workplace (Williams, 1998). Empiric evidence showed that stress was linked to
depression which frequently resulted in low medication adherence (Berkman et al., 2003;
Cohen et al., 1983).
Medication Adherence Barriers
Quality of Physician-Client Relationship or Health Care Climate
The definition of the quality of the therapeutic relationship between doctor and
patient is the degree of autonomy and the level of satisfaction the patient experiences
with the health care provider. Quality of the physician-client relationship was used
interchangeably with the term, health care climate (HCC). Adequate autonomy support
or satisfaction with the health care provider indicates that the relationship is positive or
therapeutic. The client who is not satisfied with the HCC may perceive that the HCC is
non-therapeutic. Safeer and Keenan (2005) found that the quality of the HCC was often
reflected in low MA because patients did not feel empowered to make informed choices
about their care. The patients were given orders and expected to comply with no
opportunity for discussion..
Similarly, Smith and Haggerty (2003) found that the way medication information
was disseminated by the healthcare provider impacted medication non-adherence. Good
communication between the patient and the health care provider will lead to greater
adherence and improved health outcomes (Friedman et al., 2008; Praska, Kripalana,
Seright, & Jacobson, 2005). Knowledge of the medication therapy can empower patients
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by promoting the understanding of medical problems and by increasing the patients’
involvement in decisions regarding their health.
Satisfaction with the healthcare climate or a therapeutic physician-client relationship
has been associated with more favorable medical outcomes for patients with chronic
diseases (Shea, Guerra, & Ravenell, 2004). Research suggests that information-sharing
between physician and client as well as seeking and understanding medical information
determined the therapeutic level of the HCC (Hoffman & McKenna, 2006; Williams,
McGregor, & King, 2005). Finally, Murray et al. (2004a) found that many adults often
lacked adequate transportation to the healthcare system for care and medications and for
follow up visits. It is believed that broken appointments impact the continuity in care and
strain the therapeutic relationship (Murray et al., 2004a).
Complexity of Medication Regimens
Complexity of the medication regimen was conceptualized as multiple drug therapy
including frequent dosing schedules. MetS requires multiple treatment regimens
including combination drug therapy and frequent dosing medications (Davis et al., 2006;
Grundy, 2008). Moreover, AAs with MetS frequently report multiple health comorbidities and must take multiple prescription medications including angiotensin
receptor blockers (ARB), angiotensin converting-enzyme (ACE) inhibitors, and diuretic
combination medications (Lagu et al., 2009; White, 2008; Williams et al., 2007). In a
recent study, Shaya et al. (2009) found that patients (n=568) on fixed-dose combination
therapy were more likely to display medication adherence than patients with higher comorbidities and on separate agents. Nevertheless, Lagu et al. (2009) (n=327) found that
antihypertensive prescriptions written for patients with five or more co-morbidities were
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significantly more likely to be filled versus persons with fewer co-morbidities. In a
recent study (n=498), complex regimens from multiple co-morbidities were associated
with poor blood pressure control in hypertensive AA (McDonald, Pezzin, Peng &
Feldman, 2009). Alternating dosing schedules produced 50% medication adherence
while weekly dosing resulted in 29% medication adherence (Risser, Jacobson, &
Kripalani, 2007). The research suggests that simpler medical regimens and satisfaction
with healthcare climate improved self-efficacy and led to more positive outcomes
(Williams et al., 2005).
Similarly, Banning (2009) found that reduction of quantity of medications reduced
medication complexity and led to more adherence success. Banning reported that
reduction in the quantity of medications improved medication adherence up to 20% and
increased medication adherence rates 90% versus 82%, (p < 0.01). Similarly, Haynes et
al. (2005) noted that complex medication regimens are precursors to non-adherence, due
to patients forgetting to take their medication or omission of doses.
Assumptions
Bandura (1986) found that personal factors, environmental factors, and behavioral
capability intersect in triadic reciprocity to predict health-seeking behaviors. The
following assumptions are an integral part of the theoretical framework: 1) SCT is a
model of reciprocal interaction among cognitive factors, environment, and behaviors; 2)
adults are active learners; and, 3) adults learn in social contexts.
In addition, the SCT accounted for a greater variance (23%) in health behaviors
compared to the Health Beliefs Model, suggesting a potentially greater usefulness for this
theory (Bosworth, et al., 2006). The SCT has demonstrated usefulness in its applicability
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to various patient populations and its constructs are tested frequently in medication selfmanagement studies (e.g., Bosworth et al., 2006).
The SCT will be used to examine the relationship among medication adherence,
personal, environmental, and behavioral variables in AA adults with MetS. If African
American adults with MetS follow their medical regimen, morbidity and mortality will
decline and more positive outcomes will occur (Poon et al., 2009). The SCT variables
have been examined in a variety of clinical populations and have successfully predicted
health behavior. A secondary analysis of SCT variables may yield similar results in a
cohort of African American adults with MetS.
Summary
Although hypertension medication adherence is a self-management behavior that can
greatly reduce risks for negative outcomes such as CVD, the research suggests that AA
often do not adhere to medication regimens as well as their White counterparts. In fact,
medication non-adherence is more prevalent in minority populations and it is well
documented that medication adherence may be more difficult for African American
adults than White adults. This finding is of great concern to healthcare providers given
that middle-aged African American adults have worse healthcare outcomes than their
White counterparts, and they continue to experience disparately high rates of chronic
illnesses.
Although prescription medications are the primary therapeutic regimen for AA with
multiple co-morbidities, these adults use substantially less prescription medications than
White older adults (Lagu et al., 2009). Therefore, interventions are needed to increase
health behaviors and promote more positive healthcare outcomes for these vulnerable
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adults.
Finally, empiric evidence shows that non-adherence to medication regimens
significantly contributes to burgeoning healthcare costs as well as perpetuating health
disparities. Given that the relationship among personal characteristics, environmental
factors, and medication adherence in AA adults with MetS remains unclear, an
investigation of these factors using a learning theoretical framework will advance the
science in this research area. The social cognitive theory provided the theoretical
framework for examining hypertension medication adherence in this population.

Chapter II
Review of Literature
Metabolic Syndrome Overview
Although the pathophysiology of metabolic syndrome (MetS) is still not clearly or
consistently defined (Grundy et al., 2008; Lann, Gallagher, & Leroith, 2008; Wilson &
Grundy, 2003), this accumulation of cardiovascular disease (CVD) risk factors is
associated with being overweight with large abdominal circumference (Grundy et al.,
2008; Mosca et al., 2006; Wright et al., 2008). Moreover, research suggests that MetS is
a cluster of metabolic abnormalities that increases the susceptibility to risks of coronary
heart disease (CHD) and CVD (Brown et al., 2008; Grundy, 2005). Data from
Framingham Risk Scores (FRS) suggested that MetS triples the relative risk of CVD
(Wilson, 2004). Similarly, Curtis et al. (2007) found that MetS was associated with a
38% greater risk of CVD events.
Abdominal Obesity
Abdominal obesity is commonly associated with MetS (Perry, Wang, & Kuo,
2008; Ryan et al., 2008). Abdominal obesity presents as increased waist circumference
(≥ 102 cm in men and ≥ 88 cm in women) (National Heart Lung Blood Institute
[NHLBI], 2004).
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It is well documented that individuals with a body mass index (BMI) of 25 to 29.9 kg/m2
are considered overweight, and individuals with a BMI ≥ 30 kg/m2 are considered obese
(Rocha, 2008; NHLBI, 2004). All overweight and obese adults with a BMI ≥ 25 kg/m2
are considered at risk for developing MetS (Lechleitner, 2008; Perry et al., 2008).
Atherogenic dyslipidemia
Atherogenic dyslipidemia is a triad of lipid abnormalities that includes elevated
triglycerides (greater than 150 mg/dl), decreased high density lipoprotein (HDL)cholesterol levels (less than 40 mg/dl), and a preponderance of small, dense low density
lipoprotein (LDL) particles (> 130 mg/dl) (Lechleitner, 2008; Ryan et al., 2008).
Hypertension
Hypertension (HTN) is associated with obesity and insulin resistance (Brietzke,
2007; Preiss & Sattar, 2007). The clinical criteria for HTN include a systolic blood
pressure (SBP) ≥ 140 mmHg and a diastolic blood pressure (DBP) ≥ 90 mmHg
(Bosworth et al., 2006; Chobanian et al., 2003). AA adults have a greater prevalence of
high blood pressure (39%) than Whites (29%) (Cutler et al., 2008; Ong et al., 2007).
Moreover, uncontrolled HTN in AA accounts for nearly 8,000 preventable deaths per
year from CVD events (Fiscella & Holt, 2008; Gu, Burt, Paulose-Ram, Yoon, & Gillum,
2008).
Insulin Resistance
Insulin resistance (IR) is defined as Type II diabetes mellitus (DM), impaired
fasting glucose (IFG), impaired glucose tolerance (IGT), or normal fasting glucose levels
greater than 110 mg/dl (Lann, Gallagher, & Leroith, 2008; Ren & Kelley, 2009). Insulin
resistance is strongly associated with metabolic risk factors and increases CVD risk
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significantly (Lann et al., 2008). Invariably persons with MetS are insulin-resistant, and
this insulin resistance progresses to Type II Diabetes Mellitus (Ford, Abbasi, & Reaven,
2005; Martins, et al., 2008).
Pro-inflammatory State
A pro-inflammatory state is recognized clinically as elevations of C-reactive
protein (CRP) and is most frequently observed in persons with MetS (Ren & Kelley,
2009). One underlying cause of pro-inflammation is obesity because excess adipose
tissue releases inflammatory cytokines that result in higher CRP levels (Wilson &
Grundy, 2003).
Pro-thrombotic State
A pro-thrombotic state, manifested as increased plasma plasminogen activator
inhibitor (PAI) and fibrinogen, is associated with MetS (Brietzke, 2007; Wilson &
Grundy, 2003). These authors found that fibrinogen like CRP rises in the presence of
elevated inflammatory cytokines. Research suggests that metabolically, proinflammation
and prothrombotic states are interconnected (Brietzke, 2007; Reaven, 2002).
Prevalence of MetS
MetS is a major public health problem in the United States, and according to the
U.S. Department of Health and Human Services (2004), about 50 million adults have
MetS. Currently, one fourth of U.S. adults, 20 years of age or older, meet the clinical
criteria for the diagnosis of MetS. (Brown et al., 2008; Lechleitner, 2008). Furthermore,
in overweight persons, MetS increases significantly to rates of over 50% (Ford, 2006;
Park et al., 2003).
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According to Ford (2006) males and females display comparable rates of MetS,
although it is estimated that 31% of Mexican Americans, 24% of Whites, and 22% of AA
have MetS (Park et al., 2003). Moreover, Clark & El-Atat (2007) found that although the
age-adjusted prevalence of MetS in AA (21.6%) is similar to that in overall U.S.
population (23.7%), AA women have an approximately 57% higher prevalence of MetS
than their male counterparts (25.7% versus 16.4%) (Appel, Moore, & Giger, 2006). The
prevalence of MetS increases with increasing age (44% of adults >50 years old) (Grundy,
2005; Lechlietner, 2008). Similarly, Ren & Kelley (2009) found that MetS was more
prevalent in menopausal women than in pre-menopausal women. Ren & Kelley
attributed this gender dimorphism to female sex hormones.
Diagnosis of MetS
Clinical Criteria
Given the various definitions by health organizations, it is unclear whether the
diagnosis of MetS is greater than the sum of its components (Lann, Gallagher, & Leroith,
2008). Diagnostic criteria for MetS are based on measurements done in persons who
have fasted for 12 hours or more (Brietzke, 2007; Ren & Kelley, 2009; Wilson &
Grundy, 2003). Four organizations have defined clinical criteria for the diagnosis of
MetS: 1) National Cholesterol Education Program’s (NCEP) Adult Treatment Panel III or
(ATP III), 2) International Diabetes Foundation (IDF), 3) American Association of
Clinical Endocrinologists (AACE), and 4) World Health Organization (WHO).
According to the criteria from the ATP III (1997), MetS is clinically present when three
or more of the following conditions are met: 1) waist circumference greater than 102 cm
in men and 88 cm in women; 2) serum triglyceride (TG) level of at least 1.7 mmol/L (≥
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150 mg/dl); 3) HDL cholesterol level < 40mg/dl in men and < 50mg/dl in women; 4)
blood pressure ≥ 130 mm Hg systolic or ≥ 85 mmHg diastolic ; and 5) fasting plasma
glucose level ≥ 110mg/dl (Anuurad, Chiem, Pearson & Berglund , 2007). The diagnostic
criteria used by the IDF are similar to that of the ATP III; however, the IDF uses body
mass index ≥ 30 kg/m2 instead of waist circumference (≥ 102 cm in men and ≥ 88 cm in
women) to define MetS (Vaidya et al., 2007).
The AACE proposes a third set of clinical criteria for MetS (Grundy et al., 2008).
The authors suggest these criteria are a hybrid of the ATP III and the WHO criteria;
however only clinical judgment is needed for diagnosis; therefore, no defined number of
risk factors is provided. The World Health Organization (2003) views insulin resistance
as a required component for diagnosis.
Controversies with MetS Diagnosis
In addition to insulin resistance, the World Health Organization (WHO) indicates that
two other factors are sufficient for diagnosis of MetS. The WHO requires higher blood
pressure parameters than ATP III and like IDF, WHO uses BMI instead of waist
circumference for diagnosis. Research suggests that the prevalence of MetS did not vary
based on differences in IDF and the ATP III criteria for waist circumference (Ryan,
Fenster, Abbasi, & Reaven, 2008). The requirement for clinical presence of insulin
resistance, however, is believed to predict diabetes mellitus more strongly than ATP III
(Lann, et al., 2008).
Consistent with ATP III criteria, the WHO suggests that the presence of Type II DM
does not exclude a diagnosis of MetS. A disadvantage of the WHO criteria is that special
testing for glucose is needed beyond the routine clinical assessment to diagnose MetS.
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The ATP III did not find evidence to recommend routine measurement of insulin
resistance (for e.g., increased fasting blood insulin) in their clinical criteria (Vaidya et al.,
2007).
Grundy et al. (2008) found that the use of ATP III criteria directs the focus from
insulin resistance abnormalities to focus on whether or not a patient has MetS. Grundy
found that persons can be hypertensive and hypercholesterolemic and still not meet the
ATP II criteria for MetS. This conclusion may explain why many AA are diagnosed with
MetS after the disease has already progressed (Norris et al., 2006). Moreover, in a recent
study, (n=6938), Mosca et al. (2006) found that when diagnostic criteria included waist
circumference in addition to Framingham Risk Scores (FRS), 41% of women who were
previously classified as low risk were diagnosed with three or more MetS risk factors.
Emerging Issues Related to MetS Diagnoses
Although adipose tissue in obese people is insulin-resistant, it is recognized that some
people who are not obese by traditional measures may be insulin-resistant, and insulinresistance is one essential cause of MetS (Reaven, 2002). Meis, Schuster, Gailland, &
Osei, (2006) and Perseghin et al. (1997) found that individuals with two diabetic parents
or one diabetic parent and one or two close diabetic relatives may have abnormal levels
of metabolic risk factors. Similarly, Grundy et al. (2005) found that a genetic component
was responsible for MetS susceptibility also.
Reaven (2002) concluded that failure to focus on the central role of IR often led to
interventions that increase, not decrease CHD risk. The ATP III approach to MetS
suggests that CHD risk is not limited to hypercholesterolemia, and that
IR/hyperinsulinemia and defects in insulin metabolism must be considered to decrease
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CHD risk (Grundy et al., 2008). Research suggests it is important to focus on the cluster
of metabolic abnormalities since they are more likely to occur together than separately
(Reaven, 2002).
The American Diabetes Association (ADA) recommended that the lower limit for the
diagnosis of impaired fasting glucose be changed from 6.1 mmol/L to 5.6 mmol/L
(Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2008). Tai
et al. (2004) found that the association between impaired glucose tolerance and CVD
morbidity and mortality is stronger than the association between impaired fasting glucose
and CVD. It is believed that the lower cutoff identifies more subjects at risk for diabetes
and CVD (Tai et al., 2004).
Health Disparities Related to Diagnosis
The disproportionate levels of obesity in AA translate into a disproportionate burden
of cardiovascular disease (CVD) morbidity and mortality (Lechleitner, 2008; Mensah et
al., 2005; Rocha, 2008; Ryan et al., 2008). According to NHANES III data, AA women
have the highest rate of abdominal obesity when compared to other ethnic groups in the
United States (Brown et al., 2008; Meis, Schuster, Gaillard, & Osei, 2006; Park et al.,
2003; Williams et al., 2007).
The disparity in number of AA diagnosed with MetS relative to the prevalence in
hypertension and obesity-related disorders may be due to failure to focus on the role of
IR (Reaven, 2002). The lower prevalence of MetS among AA has been explained by the
fact that two separate lipid criteria are defined by the NCEP (high triglycerides and low
HDL cholesterol), which offset higher rates of HTN and glucose intolerance in AA
(Reaven, 2002).
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Health Disparities Related to Treatment
The presence of multiple physiological determinants underlying the cluster of MetS
abnormalities supported a variety of therapeutic regimens. Brietzke (2007) however,
provided evidence that treatment of MetS should target the syndrome rather than the
components of the syndrome to reduce risks of DM and CVD.
Although AA are notably absent from many of the large clinical outcomes trials of
lipid-lowering therapy, the magnitude of LDL-C reduction with statins appears to be
similar in AAs and Whites (Grundy et al., 2008; Clark & El-Atat, 2007). In the lipid
lowering component of the Antihypertensive and Lipid Lowering Treatment to Prevent
Heart Attack Trial ([ALLHAT-LLT], Clark & El-Atat, 2007) (n=3491) (38% AA), statin
therapy more effectively lowered the risk of CHD and nonfatal myocardial infarction in
AA than in non-AA (RR 0.73 vs. 1.02, p=0.03); the 27% relative reduction in CHD
events among AA treated with pravastatin versus usual care was statistically significant
(ALLHAT, 2002). Clark and El-Atat (2007) found that older AA adults were less likely
to be treated with lipid-lowering drugs than their White counterparts.
In a recent study with veterans (n=56,561), Poon et al. (2009) found that despite
national practice guidelines recommendation of the use of angiotension converting
enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) for patients with
diabetes, AA with hypertension and diabetes were less likely to receive these drugs.
Although AA in this veterans’ cohort had more contraindications like hyperkalemia and
angioedema, which may have precluded ACE inhibitors, AA were still much less likely
than their counterparts to receive beta-blockers as first line therapy. Furthermore,
previous studies found that AA required a greater number of anti-hypertensives, and even
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with combination therapy, had much poorer blood pressure control than Whites (Giles et
al., 2007; White, 2008; Williams et al., 2007). Prevalence of uncontrolled hypertension
among AA remains significantly high, and the high use of mono-therapy in AA is
questionable (Chobanian et al, 2003; Lagu et al., 2009; White, 2008).
MetS Long and Short-Term Health Outcomes
Consequences of Uncontrolled MetS
MetS is categorized by multiple risk factors that confer greater risks for adverse
clinical outcomes compared to a single factor (Blank & Brunton, 2008; Chen et al.,
2004). In one study (n=3323) Wilson (2004) found that MetS alone predicted 25% of all
new onset CVD. Similarly, Curtis et al. (2007) found that MetS was associated with a
38% greater risk of CVD events. Also, almost half of the population’s attributable risk
for diabetes was explained by MetS (Wright et al., 2008).
Coronary Heart Disease/Cardiovascular Disease
The ATP III viewed CVD, the largest cause of death in the United States (American
Heart Association [AHA], 2007), as the primary clinical outcome of MetS. MetS
increases CVD risk 4-fold (Clark & El-Atat, 2007). Research suggests that AA have the
highest mortality rate from CHD of any ethnic group, especially at younger ages
(Anuurad, et al., 2007; Hilgers & Mann, 2008; Wright et al., 2008).
Diabetes Mellitus (DM)
In a recent study, Yatskar et al., (2008) (n=510) found that MetS predicted
development of diabetes mellitus (DM) for patients who did not have DM at baseline.
Type 2 DM is the second leading cause of death in AA women. Insulin resistance is
present in most people with MetS. Insulin resistance is associated with other metabolic
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risk factors and increases CVD risk significantly (Grundy et al., 2008). Research
suggests the associations underlying the link to CVD risk factors are unclear, so the ATP
III classifies IR as an emerging risk factor. According to Grundy and colleagues,
persistent IR accelerates glucose intolerance, another emerging risk factor in MetS.
Glucose intolerance frequently leads to DM-level hyperglycemia, a significant
independent risk factor for CVD. DM is diagnosed in 10.3 million Americans, and it is
projected that 5.4 million Americans are undiagnosed (Expert Committee, 2008). The
American Diabetes Association (Expert Committee, 2008) estimates that 2.8 million
(13%) AAs have DM, and another 7% has impaired fasting glucose (IFG) which is a
precursor to DM.
Other MetS Clinical Sequelae
MetS is a significant contributor to End-Stage Renal Disease (ESRD) (Gilbertson et
al., 2007). Although AAs comprise 12% of the US population they represent almost 30%
of those with ESRD (Gilbertson et al., 2007). Other clinical sequelae associated with
MetS are chronic kidney disease (CKD) (Appel et al., 1997; 2008), nonalcoholic fatty
liver disease (NAFLD), and obstructive sleep apnea (OSA) (Grundy et al., 2008).
MetS Summary
The literature shows that MetS is a significant determinant of CVD (e.g. Annurad,
Chiem, Pearson, & Berglund, 2007; Blank & Brunton, 2008; Shaista et al., 2004). In a
Framingham follow up study (n=3323), Wilson (2004) found that MetS alone predicted
25% of all new onset CVD; and for both genders, almost half of the population
attributable risk for diabetes was explained by MetS. Similarly, Shaista and colleagues
looked at the impact of MetS on mortality from CHD/CVD and all causes in US adults.
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The authors found that MetS was associated with hazard risk (HR) of 2.02 after
controlling for age, gender, smoking status, and total cholesterol. Patients with MetS had
HR of CHD mortality of 1.65. HR for CHD mortality was 2.1 for persons with one or two
risk factors, compared with those with no MetS (Shaista et al., 2004).
Although CVD mortality has declined overall over the past decade, AA continue to
suffer a disproportionate burden of CVD disease mortality and morbidity (Wright et al.,
2008; Hilgers & Mann, 2008; Annurad, et al., 2007). In fact, AAs have the highest death
rates of any of America’s racial and ethnic groups related to CVD events: 319 per
100,000 person years for AA women and 423 per 100,000 for AA men compared to 278
per 100,000 person years for all other ethnicities combined (CDC, Vital Statistics Report,
2006; Henderson et al., 2007). The literature review reveals that a significant contributor
to health disparities is low medication adherence; this important healthcare issue will now
be addressed in detail.
Medication Adherence
Overview
Medication adherence (MA) is the extent to which medical orders and health
recommendations are followed as defined by the healthcare provider (Osterberg &
Blaschke, 2005; Vlasnik et al., 2005). Medication non-adherence may be a deliberate or
an unintentional deviation from therapeutic regimens and medical interventions (George
& Shalansky, 2007; Nyatanga, 1997; Reynolds et al., 2004). Some older adults may
forget to take their medications because of memory impairments, while others choose not
to take the medication. Intentional medication non-adherence implies that patients refuse
to comply with the regimen, or fail to carry out or deviate from specific behaviors after

38
making an informed choice (Nyatanga, 1997). Often, when older adults encounter
unfavorable effects, they may stop taking the medication without consulting with their
health care provider; others stop taking the medication the moment they start feeling
better.
Causes of Medication Non-Adherence
Medication non-adherence in older adults has many causes, including: 1) stress, 2)
depression, 3) low health literacy, 4) poor quality of the therapeutic relationship, 5)
complexity of the medication regimen, and 6) lack of adequate social support.
Stress
It is believed that chronic illnesses predispose individuals to stress and stress leads to
medication non-adherence (Cohen et al., 1983; Sewitch et al., 2003). The stress of doing
blood sugar checks or blood pressure checks may cause patients not to engage in
self-management behavior and thus they become non-adherent in their medical regimen.
For example, Sewitch et al. (2004) found that patients (n=182) who were not taking their
medications had more elevated stress than those who took their medications; the exact
mechanisms underlying this relationship between stress and MA were unclear.
Research suggests that several MetS components have been linked to adrenocortical
and autonomic disturbances (Berkman et al., 2003; Virtanen et al., 2003). In fact, the
relationship between stress induced neuro-hormonal abnormalities, visceral fat, and
insulin resistance is well-established (Berkman et al., 2003). Since psychosocial factors
explained some of these associations, it was suspected that stress-induced activation of
the sympathoadrenal system or the hypothalamic-pituitary-adrenocortical (HPA) axis
may contribute to MetS or that stress may be etiologically linked to MetS (Berkman,
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Blumenthal, Burg, et al, 2003).
In addition, research provided evidence that negative situations frequently lead to
psychological and physiological stress, which contribute to negative healthcare outcomes
(Berkman et al., 2003; Cohen, Kamarck, & Mermelstein, 1983; Williams, 1998). A
compounding of negative effects compromises health and frequently leads to stress and
depression which are significant correlates of medication adherence (Bane, Hughes, &
McElnay, 2006; Reynolds et al., 2004). Cumulative disadvantage and multiple-jeopardy
often cascade into stressful precipitating factors which contribute to burgeoning racial
and ethnic disparities (Dannefer, 2003).
Furthermore, the literature suggests that environmental demands predispose
individuals to psychological stress (Berkman et al., 2003; Cohen et al., 1983; Steptoe et
al., 2006; Williams, 1998). Research suggests that the availability of healthcare
management resources impact stress, which frequently alters bio-behavioral responses
that contribute to increased risk factors for cardiovascular disease (Williams, 1998). In
fact, CHD patients were found to have more elevated stress hormones and were more
likely to be depressed (Steptoe et al., 2006). In addition, stress precipitates and
exacerbates depression which affects about 20% of patients with coronary artery disease
(CAD) and depression is an important risk factor for death and acute cardiac syndrome
(ACS) (Berkman et al., 2003; Steptoe et al., 2006). Notably, Williams (1998) found that
the added effects of race, discrimination, and low economic capital contributed to stress
and negative health outcomes for AA adults. Finally, it was well-documented that
psychological stress is linked to depression in a variety of clinical populations (Berkman
et al., 2003; Knox et al., 2008; Steptoe et al., 2006).
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Depression
Depression is associated with a failure to activate neural circuitry including the areas
of the medial prefrontal cortex and the hippocampus, which prevent inputs to the
amygdala (Strike et al., 2006). Inhibition of the amygdala frequently leads to peripheral
activation of the cardiovascular and neuro-hormonal responses through the
hypothalamus-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS)
(Strike et al., 2006). These pathways increase the risk of mental stress ischemia and
contribute to both damage of the vasculature, especially endothelial tissue, and vascular
resistance in CAD patients with depression (Berkman et al., 2003).
Research suggests that depression appears to increase the risk of heart disease and is
associated with poorer prognosis among cardiac patients (Steptoe et al., 2006). Current
data supported a positive association between depression and CHD, although the
mechanisms mediating these associations remain unclear (Knox et al., 2008).
Predictors of Depression
Low Health Literacy
Low health literacy is a powerful predictor of depression symptomatology in
older adults (Baker, Gazmararian, Sudano & Patterson, 2002; Gazmaraian, Baker, Parker,
& Blazer, 2000). Some research shows that older adults with poor health literacy are
more likely to show major depressive symptoms than their counterparts with adequate
health literacy (Baker et al., 2000; Gazmararian et al., 2000). In fact, the research
suggests that adults with inadequate health literacy are more than twice as likely to be
depressed compared to their health literate counterparts.
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Stress-related Factors
Knox and colleagues (2008) posited that depression in AA is very prevalent due to a
convergence of societal and biological factors related to stress. This stress may be caused
by racial discriminations and cumulative disadvantage from a lifetime of elusive
opportunity structures or income and education (Williams, 1998). Moreover, the stigma
of mental health in AA precludes traditional therapy and compounds health disparities
related to CVD and DM.
In a recent study (n=112), Artinian et al (2009) found that AA starting phase II
cardiac rehabilitation with depression symptoms at or above threshold had more stress
and fewer stress-resilience factors than their White counterparts. Similarly, Knox and
colleagues (2008) found that AA showed significant associations between history of
depression and diabetes that did not exist in Whites, and AA women had significantly
more episodes of depression than any other group. Moreover, the associations of
depression with body mass index and physical activity were consistent across racial
groups. In addition, HDL-cholesterol and LDL-cholesterol levels were associated with
depression. In fact, these data indicated that there were positive associations between
depression and factors that predispose to stress and cardiovascular risk (Knox et al.,
2008; Sud et al., 2005). The association of depression and medication adherence will
now be examined.
Depression and Medication Adherence
Reynolds et al. (2004) provided evidence that depression was the strongest correlate
of non-adherence, and medications to treat chronic illnesses may intensify depression.
These researchers noted that physiological changes with aging may also intensify the
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effects of antidepressant medications. In addition, depression from multiple medications
often masks symptoms for other chronic conditions (Reynolds et al., 2004). For example,
symptoms from dementia, stroke, and Parkinson’s disease overlap or mimic symptoms of
depression.
Research shows that medication non-adherence because of depression negatively
influences individuals’ perceptions about health and quality of life (Bane et al., 2006).
Similarly, Schoenthaler and colleagues (2007) found that self-efficacy mediated the
relationship between depression and medication adherence in hypertensive AAs.
Moreover, it is well established that non-adherence subsequent to depression, negatively
influences individuals’ perceptions about health and quality of life (Bane et al., 2006;
Schoenthaler et al., 2007).).
Nyatanga (1997) argued that medication non-adherence should not be construed as an
act of defiance. Nyatanga (1997) found that psychosocial theories such as depression
were helpful in explaining and understanding non-adherence in medication regimens.
Nyatanga posited that depression was associated with non-adherence with medication
regimens. Similarly, Gazmararian et al. (2000) interviewed 3260 Medicare enrollees
over a six-month period. These adults had a high prevalence of chronic conditions. The
authors found that 13% of the respondents were classified as depressed. Gazmararian et
al. (2000) noted that individuals with low health literacy were 2.7 times more likely to be
depressed relative to adults with adequate health literacy skills.
The results of these studies provided evidence that adults with depression were more
likely to be non-adherent with their medications and adults with low health literacy skills
were more likely to report major depressive symptomatology (Schoenthaler et al., 2007).
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In fact, health literacy was consistently linked to negative healthcare outcomes (Baker et
al., 2002; Gazmararian et al., 2000). Health literacy will now be addressed in greater
detail.
Health Literacy
Definition
Health literacy, as defined by the Institute of Medicine (IOM) (2004) in Healthy
People 2010, is “the degree to which individuals have the capacity to obtain, process, and
understand basic health information and services needed to make appropriate health
decisions.” Low health literacy is a lack of ability to obtain and understand health
information in a way that helps people take charge of their health (Gazmararian, et al.
2003).
Low Health Literacy
The research reveals that older adults frequently display low health literacy (Murray
et al, 2004). Low health literacy limits knowledge of risk factors and causes of disease,
and it limits individuals’ ability to seek health information that may promote health and
prevent disease (Davis et al., 2006; Smith & Haggerty, 2003; Wallace et al., 2006).
Research suggests that low health literacy may reduce one’s ability to manage health
(Hoffman & McKenna, 2006; Nath, Sylvester, Yasek & Gunel, 2001). In fact, health
literacy may be linked to utilization of treatments that may be available to individuals
(Lauber, Nordt, Falcato, & Rossler, 2003; Montalto & Spiegler, 2001). It appears that in
the absence of adequate health literacy skills, appropriate health-seeking behavior
diminished considerably (Davis et al., 2006).
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Low Health Literacy and Patient Knowledge
According to Hixon (2004) and Safeer and Keenan (2005), lower levels of health
literacy are associated with less knowledge about chronic disease conditions, poorer
health status, and increased rates of hospitalization, which result in higher healthcare
costs. Recently, the Mayo clinic found that 15% of patients were unaware they were
being prescribed a new medication; only half knew specific information about their
medications related to dosage, dosing schedules, and purpose (Kripalani et al., 2006).
In a related study (N=130) Toren, Kerzman, Koren, and Baron-Epel (2005)
examined patients’ knowledge regarding medication therapy and the association with
health services utilization. Patients were discharged with new prescriptions for long term
medications. About 60% of patients reported receiving no counseling regarding their
new medications. The authors found that 18% of the patients visited the emergency
department during the month after discharge, of whom 35% visited twice or more. The
findings indicated that higher levels of patient knowledge were associated with higher
levels of health services utilization (OR = 4.76, 95% CI: 1.74-13.06).
Prevalence of Low Health Literacy
National Statistics
The Institute of Medicine (IOM) and the National Academies of Science (2001)
estimated that 90 million adults have low health literacy (IOM, 2004). Health literacy
research findings include the results from the 2003 National Assessment of Adult
Literacy (Rudd, Kirsch, & Yamamoto, 2004) which indicated that up to 20% of the total
population demonstrated skills in the lowest levels of literacy of prose, document, and
quantitative literacy, while 25-28% of the nation scored in the lowest levels of literacy
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scales. Although low health literacy appears to transcend educational level, gender,
socio-economic status, and health status (Benson & Forman, 2002; Schillinger, Barton,
Karter, Wang, & Adler, 2006), minority groups consistently scored 43 to 73 points lower
than Euro-Americans on health literacy, while 71% of older adults ages 65 and older
scored in the two lowest levels of literacy (National Center for Educational Statistics,
2003; Rudd et al., 2004).
Low Health Literacy and Socioeconomic Status
Although low health literacy is frequently linked to low socioeconomic status,
research showed that the problem of poor health literacy was present in affluent,
predominantly college-educated communities (Benson & Forman, 2002). In this study,
93 residents were administered the Test of Functional Health Literacy in Adults
(TOFHLA). The residents had a mean age of less than 70 years, were not acutely ill, had
no known loss of mental functioning, were better educated, and had a high standard of
living compared to national standards. The authors found that 30% of the group was
unable to adequately comprehend common written health care information as measured
by the TOFHLA. These researchers were especially alarmed by the poor comprehension
of an informed consent document. They demonstrated that of those with poor
comprehension, only 68% could understand prescription directions as labeled on
medication bottles (Benson & Forman, 2002).
Low Health Literacy and Older Adults
The researchers noted that older adults were more likely to have inadequate
functional health literacy and chronic and co-morbid health conditions (Baker, et al.,
2000; Paasche-Orlow et al., 2005). Some evidence indicates that low health literacy in
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older adults may be related to perceptual, sensory, and cognitive decline that occurs with
normal aging (Hertzog & Hultsch, 2000).
In fact, older adults had lower health literacy compared with young adults and were
more likely to have difficulty reading labels and understanding instructions (Benson &
Forman, 2002 ; Davis et al., 2006; Hoffmann & McKenna, 2006). Sorrell (2004) showed
that in older adults knowledge deficits included lack of information regarding adverse
drug reactions and interactions, lack of information on efficacy of specific therapies, and
general uncertainties regarding the medications.
Low Health Literacy in African American Adults
African American adults continue to report significant levels of poor functional health
literacy, which may be linked to disparate rates of medication non-adherence and poor
health outcomes (Davis et al., 2006; Gazmararian et al., 2006; Georges, Bolton, &
Bennett, 2004; Schillinger et al., 2006). AAs with MetS frequently have multiple comorbidities and must take multiple prescription medications including Angiotensin II
Receptor Blockers (ARB), Angiotensin-Converting Enzyme (ACE) inhibitors and
diuretic combination medications (Hendrix et al., 2005; Lagu et al., 2009). Therefore, on
a daily basis, AA adults must read and understand a variety of health information related
to their medical regimen (Sentell & Halpin, 2006; Wolf et al., 2006).
Health Literacy and Cognitive Status
Other studies (Baker et al., 2002; Gazmararian et al., 2000) have shown that adults
with low health literacy reported lower scores on the Mini Mental Status Exam (MMSE),
indicating that low health literacy, measured using the Short Test of Functional Health
Literacy in Adults (S-TOFHLA) may result from true differences in cognitive
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functioning. The researchers found that functional health literacy was related to MMSE
scores across the entire range of S-TOFHLA scores (Baker et al., 2002). MMSE scores
were not adjusted for an individual’s functional health literacy because the researchers
felt that it would mask true differences in cognitive functioning.
As indicated previously, health literacy is not necessarily a function of educational
attainment or poverty status (Baker et al., 2000; Benson & Forman, 2002; Gazmararian et
al., 2000). Declines in memory predispose older people to low health literacy because
older people have more difficulty remembering and must employ strategies to
compensate for memory deficits (Hertzog & Hultsch, 2000). These researchers found
that older adults also seem to be disadvantaged with regard to time-based prospective
memory tasks. As noted by the researchers, prospective memory involves remembering
to do something or perform an action in the future. Health literacy is important to the
general health status of older adults, since, on a daily basis, they must understand various
types of spoken and written discourse that pertains to their health (Benson & Forman,
2002; Gazmararian et al., 2006).
Importance of Adequate Health Literacy in Older Adults
Webster and Perry (2005) stated that medication self-administration in older
adults needs more attention because positive health outcomes were frequently
compromised by the prevalence of medication errors (Hoffman & McKenna, 2006;
Morris et al., 2006). Webster and Perry noted that, in older adults, outpatient medication
errors are four times those of inpatient errors and suggested that this problem is underdiagnosed because of providers’ limited gero-pharmacology knowledge. For older
people, medications constitute the most common therapeutic interventions for diseases
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and are very common as a part of health promotion and disease prevention (Haynes, et
al., 2005; Vermiere et al., 2001).
Adequate health literacy is important because older adults must understand various
types of spoken and written discourse that pertains to their health (Haynes et al., 2000;
Hixon, 2004; Krousel-Wood et al., 2004; Montalto & Spiegler, 2001; Sorrell, 2004).
According to Lauber, et al. (2003), for proper health maintenance and health promotion,
it is critical that older adults understand the following: (1) instructions for taking their
medications; (2) adherence with medication regimen; (3) purpose of drug, action, and
side effects; and (4) food and drug interactions. The ability to read and understand health
information has been identified as a critical factor in maintaining independent activities
of daily living in older adults (Benson & Forman, 2002; Johnson, Diab, Kim, &
Kirschblum, 2005; Meadows, 2000).
Researchers are consistent in the finding that adequate health literacy and knowledge
about health, health care, hospitalization, and chronic diseases affected health outcomes
(Baker et al., 2007; Davis et al., 2006; Kutner, Greenberg, Ying, & Paulsen, 2006;
Paasche-Orlow & Wolf, 2007; Peterson & McGhan, 2005; Schillinger et al., 2006). For
example, Safeer and Keenan (2005) found that in a diabetes Type 2 population,
participants with low health literacy reported more negative health outcomes such as
poorer glycemic control and higher levels of diseases of the retina compared to their
counterparts with adequate health literacy. In a related study (n=398), Cavanaugh et al.
(2008) found that lower diabetes numeracy scores (knowledge of blood glucose levels
and sliding scales) were associated with older age, nonwhite race, fewer years of
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education, lower reported income, lower literacy and general numeracy skills, lower
perceived self-efficacy, and worse self-management behaviors.
Health Literacy and Medication Adherence
Voluminous literature revealed that medication non-adherence in older people was
due in large part to low health literacy (Davis et al., 2006; Gazmararian et al., 2000;
Gazmararian et al., 2006; Haynes et al., 2005; Morris et al., 2006; Roth & Ivey, 2005;
Sentell & Halpin, 2006; Wallace et al., 2006). These researchers found that adults with
adequate health literacy were more adherent to medical regimens than those with low
health literacy.
Health Literacy, Medication Adherence and Chronic Illnesses
Although the relationship between low functional health literacy and low medication
adherence has been documented in several populations with chronic illnesses
(Gazmararian et al., 2006; George & Shalansky, 2007; Kurella, Lo, & Chertow, 2005;
Mochari et al., 2007), this relationship has not been investigated in a MetS population.
Given the multiple risk factors of MetS and its complicated etiology, the relationship
between MetS outcomes and health literacy warrants further elucidation. For example, in
a recent study, poor hypertension control was directly linked to the failure of patients to
understand medical recommendations and dietary requirements (Osterberg & Blaschke,
2005; Shea, Guerra, & Ravenell, 2004). Similarly, in a related study, (n=84) Kripalani et
al., (2006) found that patients delay filling prescriptions and have difficulty
understanding medical regimen after discharge; interventions, such as discharge
counseling, might be beneficial. The authors found that medication non-adherence was
significantly more common among patients who reported difficulty understanding the
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discharge instructions (71%) versus those who had no difficulty (41%) (p =.02)
(Kripalani et al., 2006).
Medication Adherence Barriers
Quality of Therapeutic Relationship or Health Care Climate
Safeer and Keenan (2005) found that the quality of the physician-client relationship
was reflected in non-adherence with the medication regimen. Similarly, Smith and
Haggerty (2003) found that the way medication information was disseminated by the
healthcare provider impacted medication non-adherence. For example, the physician
sometimes made verbal changes to the regimen without communicating the change to the
pharmacy, or the physician did not have complete information about the patient’s current
medications. Patients’ misuse and lack of understanding of medical terminology also led
to medication non-adherence (Davis et al., 2007; Friedman et al., 2008; Shea et al.,
2007). Physicians may make behavioral errors by ordering prescriptions over the phone
without examining the patients, by inappropriate dosing, and by failing to get a history of
medications and current drug use from older clients (Chew et al., 2004; Davis & Wolf,
2004). Often, physicians do not instruct the patients adequately about the condition for
which the drug is used, the pharmacodynamics of the drugs, adverse effects, and how
long the drug should be taken (Chew et al., 2004; Kim, Hill, Bone, & Divine, 2000;
Davis & Wolf, 2004). Much generalization in how medication is administered exists,
especially in geriatric populations (Davis et al., 2006; Reynolds et al., 2004). This means
that clinicians frequently use a “one size fits all” approach instead of using an
individualized approach for older adults.
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Knowledge of medication therapy can empower patients by promoting the
understanding of medical problems and by increasing involvement in decisions regarding
their health (Toren et al., 2005). Inaccurate lay public understanding of hypertension and
its sequelae contributes to decreased rates of adherence with medical regimen (Hilgers &
Mann, 2008; Middleton, 2009). African American adults with MetS frequently lacked
the cognitive abilities to understand their health information to make informed choices
(Hilgers & Mann, 2008). Older adults sometimes forgot to take their medications or
lacked resources to navigate the healthcare delivery system effectively (Banning, 2009;
Rudd, Kirsch, & Yamamoto, 2004).
Emerging research suggests that a lack of information about disease process in AA
adults with MetS contributes to low medication adherence (Grundy et al., 2005). Toren
et al. (2005) examined patients’ (n=130) knowledge regarding medication therapy and the
association with health services utilization. The authors found that higher levels of
patient knowledge were associated with higher levels of health services utilizations (OR
= 4.76, 95% CI: 1.74-13.06). In addition, evidence supported the positive relationship
between knowledge and positive health behaviors (Middleton, 2009). It is expected that
older AA’s knowledge of MetS etiology and knowledge about the medication regimen
will play a critical role in improving medication adherence (Toren et al. 2005).
Effective patient-provider communication has been associated with more favorable
medical outcomes for patients with chronic diseases (Shea et al., 2007; Williams, 1998).
Williams (1998) provided evidence that an autonomy supportive environment was critical
to positive health care outcomes. Moreover, research suggests that patients’ seeking and
understanding medical information is a crucial aspect of information sharing between
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physician and client (Hoffman & McKenna, 2006). Murray et al. (2004a) found that
older adults often lacked adequate transportation to the healthcare system for care and
medications, and for follow up visits. It is well established that broken appointments
impact the continuity in care and strain the therapeutic relationship (Murray, et al.,
2004b).
Complexity of Medication Regimens
It is well-documented that AAs with MetS must take multiple prescription
medications including ARB, ACE inhibitors, and diuretic combination medications
(White, 2008; Williams et al., 2007). Consistent with JNC7 recommendations, White
(2008) found that combination therapy was a strategy that simplified the regimen while
providing first line therapy in high-risk patients. In a recent study, Shaya et al. (2009)
found that patients (n=568) on fixed-dose combination therapy were more likely to
display medication adherence than patients with higher co-morbidities and on separate
agents. Nevertheless, Lagu et al. (2009) found that antihypertensive prescriptions written
for patients (n=327) with five or more co-morbidities were significantly more likely to be
filled versus prescriptions written for persons with fewer co-morbidities. Prescription
medications are the primary therapeutic regimen for AA adults with multiple comorbidities (Lagu et al., 2009). On the other hand, AA adults use substantially less
prescription medications despite having a higher incidence of chronic illness.
Consequently, morbidity and mortality increase, coupled with an increase in healthcare
expenditures of more than $100 billion a year (Frishman, 2007).
MetS requires collaborative treatment including combination drug therapy and
frequent dosing medications (Davis et al., 2006; Grundy, 2008). In a recent study

53
(n=498), complex regimens from multiple co-morbidities were associated with poor
blood pressure control in hypertensive AA (McDonald et al., 2009). Alternating dosing
schedules produced 50% medication adherence while weekly dosing resulted in 29%
medication adherence (Risser et al., 2007). The research suggests that simpler medical
regimens and satisfaction with healthcare climate improved self-efficacy and led to more
positive outcomes (Williams et al., 2005).
Similarly, Banning (2009) found that reduction of quantity of medications reduced
medication complexity and led to more adherence success. Banning reported that
reduction in the quantity of medications improved medication adherence up to 20% and
increased medication adherence rates 90% versus 82%, (p < 0.01). Similarly, Haynes et
al. (2005) noted that complex medication regimens are precursors to non-adherence, due
to patients forgetting to take their medication or omission of doses. Older people must
take medications for longer periods of time and utilize drugs differently based on agerelated pharmacokinetics. Also, they have to assimilate more medication information
with more deficits in memory and cognition (Wilson, 2000).
Environmental Factors
It is well established that self-management occurs in a context of social networks
including healthcare providers, family, and informal social network members (BrenyBontempi, Burleson & Lopez, 2004; Gallant, 2003). Moreover, MetS is a lifelong
chronic disease that is punctuated with frequent consultations with healthcare providers
for ongoing education and social support (Gallant, 2003). Family and friends are sources
of emotional and instrumental social support as they provide encouragement to highlight
positive outcomes (Lee & Sharpe, 2007).
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Social Support
Haslam, Pakenam, and Smith (2006) defined social support as interpersonal
transactions that provide individuals with esteem, stress-related aid, and emotional
assistance. The external environment includes the AA adults’ home, community, social
capital, and the level of support derived from these resources (Murray et al., 2004a).
Social support is frequently linked to medication adherence. For example, Schillinger et
al. (2006) found a positive relationship between social support and self-efficacy in
diabetic populations. Similarly, research shows the positive effects of social support such
as greater self-regulation, more involvement in the health care regimen, and greater
medication adherence in populations with chronic illnesses (Bosworth et al., 2006;
Gallant, 2003; Lee & Sharp, 2007; Murray et al., 2004a).
In a related study, Ogedegbe et al. (2004) found that hypertensive AA (n=106)
reported facilitators to medication adherence were good social support and good patientdoctor relationships. This empiric work suggests that older adults with MetS who
express high levels of social support will express high levels of confidence in their
abilities to manage their medications. If African American adults are empowered to be
actively involved in their healthcare decisions, they will be more likely to follow their
medical regimen as prescribed. Similarly, African American adults with greater
confidence in their medication-taking ability will be more likely to take their medications
as prescribed.

55

Consequences of Medication Non-adherence
Negative Effects on Health Outcomes
Medication non-adherence has negative effects on health outcomes because AA
adults frequently have chronic conditions and are subject to multiple co-morbidities
(Fang, Machtinger, Wang, & Schillinger, 2006). In a cohort of renal transplant patients,
Nevins et al. (2001) found that medication non-adherence led to acute rejection and
outcomes. Similarly, Bosworth et al. (2006) found that non-adherence with
antihypertensive medication was a key factor in the failure of antihypertensive therapy.
In addition, low medication adherence to antihypertensive regimens contributed to
additional health care costs, reduction in therapeutic value, and increases in the risk for
complications from MetS (Frishman, 2007; Osterberg & Blaschke, 2005). Safeer &
Keenan (2005) found that many hospital admissions due to medication non-adherence
resulted in an additional $69 billion in healthcare costs annually. Treatment costs for
uncontrolled hypertension approach $100 billion a year (Frishman, 2007); therefore,
medication non-adherence is a critical issue for AA adults.
Medication adherence consistently predicts positive health outcomes (Schillinger
et al., 2006), and it is well documented that hypertension medication non-adherence may
be implicated in disparately high rates of CVD morbidity and mortality in African
American adults (Angell et al., 2008; Munger, Van Tassell, & Lafleur, 2007; Wright et
al., 2008). Research illuminating the factors that predict hypertension medication
adherence in AA adults is the next step that is needed in advancing the science in health
disparities research.
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Predicting Hypertension Medication Adherence
Predicting self-management behaviors, including medication adherence, has been the
aim of numerous empirical studies (Gallant, 2003; Gazmararian et al., 2006; Kripalani et
al., 2006). Many variables which consistently predict health behaviors have been
identified in these studies. In particular, several factors have been found to influence the
decision to take prescription medications as prescribed by the healthcare provider. These
factors include personal characteristics, health knowledge, and medication-taking barriers
such as complexity of medication regimen, and low satisfaction with the healthcare
climate (Bosworth et al., 2006; Gallant, 2003; Gazmararian et al, 2006; Kripalani et al.,
2008; Williams et al., 2000). Finally, it is well established that low health literacy is
associated with medication non-adherence (Davis et al., 2006; Gazmararian et al., 2003).
Medication adherence has been examined in a variety of patient populations,
including those with cancer, diabetes, hypertension, CHD, as well as patients with CVD.
Given that MetS is associated with an elevated burden of diabetes mellitus (DM) and
CVD, self-efficacy for hypertension medication-taking is an integral part of interventions
for improving MetS and its components (Hilgers & Mann, 2008; Wright et al., 2008). In
a related study, Bosworth et al. (2006) found that non-adherence with antihypertensive
medication was identified as a key factor in the failure of antihypertensive therapy.
Similarly, Ngamvitroj and Kang (2007) provided evidence that knowledge, social
support, and self-efficacy were significant independent predictors of medication
adherence. For persons with MetS, poor adherence to blood pressure medications can
lead to CVD (Bosworth et al., 2006; Ford, 2006). Phelan, Wadden, & Berkowitz (2007)
examined the effects of lifestyle modification and pharmacotherapy in MetS patients
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(n=224), and found that MA resulted in reduced MetS prevalence. However, the
literature revealed that the problem of medication non-adherence is very prevalent in
minority populations (Baker et al., 2007; Chobanian et al., 2003; Schillinger et al., 2006).
In particular, research shows that AA adults frequently displayed low medication
adherence behavior although prescription medications were the primary therapeutic
regimen for their chronic illnesses (Murray et al., 2004a). This finding is important
because AA adults continue to experience significant health disparities including shorter
life expectancies. Therefore, factors that influence medication adherence in this
population warrant further investigation. Finally, it is critical that risk factors for low
medication adherence be identified early so that interventions can be implemented to
promote positive healthcare outcomes for AA adults.
Literature Review Summary
Multiple physiological determinants are responsible for the cluster of abnormalities
known as MetS (Grundy, et al., 2008; Ren & Kelley, 2009;). The risk, however, for
MetS is highest in persons with diabetes, or pre-existing CVD, but persons with MetS
incur a significant risk for CVD events (Ren & Kelley, 2009; Brietzke, 2007; Preiss &
Sattar, 2007). Sudano and Baker (2001) found that middle-aged AA (73%) were less
likely to follow medication regimens compared with their White counterparts (64%).
The authors conducted a comparative study but did not provide rationale for this behavior
except to suggest that the behavior was predicted by personal factors.
It is well-established that poor hypertension medication adherence leads to disease
progression. For example, uncontrolled hypertension leads to MetS which is a primary
determinant of CVD (Grundy et al., 2005). Emerging research suggests that low
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hypertension medication adherence may contribute to disparately worse health outcomes
for middle-aged AA with MetS. Of particular concern to healthcare providers is the
finding that individuals diagnosed with MetS are at considerable risk for acute coronary
events. Moreover, empiric evidence suggests relationships among low health literacy,
stress, depression, a poor healthcare climate, and complexity of the medication regimen
and medication non-adherence may contribute to negative healthcare outcomes in a
variety of clinical populations. However, the research is inconclusive and further
investigation is warranted. It is suspected that a lack of information about the disease
process and MetS etiology, limited knowledge of hypertension, and a complex
medication regimen are predictors of low hypertension medication adherence in adults
with MetS (Grundy et al., 2005; Toren et al., 2005). Therefore, it is believed that if AA
adults with MetS are provided with clear, simple health information, they will be more
likely to follow their hypertension medication regimens which will result in reduced
morbidity and mortality in later life, and thus facilitate more positive outcomes for them
(Poon et al., 2009).
Gaps in Literature
AA adults were noticeably absent from many of the large clinical outcomes trials
of lipid-lowering therapy. In fact, although many epidemiological studies included
samples of adolescents and few middle-aged adults; the sample populations lacked
diversity, as they were primarily White.
Moreover, medication adherence research spans over 30 years, yet little of this
research addressed the topic from an AA perspective. In fact, AA adults are still grossly
under-represented in much of the literature that examines health literacy and medication
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adherence in other clinical populations (Osterberg & Blaschke, 2005). In addition, most
studies looking at MetS outcomes have been examined in populations outside the U.S.
(Shaista et al., (2004).
Medication adherence barriers specific to AAs with MetS were not welladdressed in the literature, nor was the association among social support, health literacy,
and self-management behaviors. Although extensive research has been conducted to
examine the relationships between social support and positive health outcomes, little of
the research has examined the relationship between social support and health literacy in
terms of health outcomes in AA adults with MetS. In addition, few research studies
included theoretical frameworks to guide research related to African Americans’ MetS
health outcomes.
Research Questions
Based on the literature review describing links among personal characteristics and
environmental factors, the following research questions were posed:
Question 1: What is the relationship of personal factors (age, gender, income, depression,
co-morbidities, and education), behavioral capability (health literacy), and medication
adherence in African American adults with MetS?
Question 2: What is the relationship between environmental factors (stress and social
support), barriers (complexity of the medication regimen and quality of the therapeutic
relationship) and medication adherence in African American adults with MetS?
Question 3: Will age, gender, income, education, health literacy, complexity of the
medication regimen, and quality of the therapeutic relationship explain a greater variance
in medication adherence over and above social support, stress, and depression in African
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American adults with MetS?
Question 4: Will African American adults with adequate behavioral capability (health
literacy) report greater medication adherence than those with inadequate behavioral
capability (health literacy)?

Chapter III
Methods
Study Design of Proposed Study
A secondary analysis of data from a large collaborative participatory action
research study, the Morehouse and Emory are Teaming up to Eliminate Cardiovascular
Health Disparities (META- Health) (U.S. Department of Health and Human Services
[HHS], 2004 -2010) was conducted. META-Health is a collaborative study with multiple
aims designed to investigate racial disparities in African Americans (AAs) with
metabolic syndrome (MetS) at risk for cardiovascular events in a larger southeastern
urban community. The secondary analysis identified relationships that might suggest
areas where healthcare providers could intervene, as well as identified some specific
personal characteristics and environmental factors that healthcare providers need to be
cognizant of in order to provide more culturally congruent care to promote more positive
health outcomes for vulnerable persons such as this cohort of AA adults with MetS.
The proposed secondary analysis used a cross-sectional, correlational design to
investigate the relationship between personal characteristics, behavioral capability,
environmental factors, and HTN medication adherence in AA adults with MetS.
Although the larger META-health study used longitudinal data, the proposed secondary
analysis only used the baseline data collected from the larger study.
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Description of Original Study
The original META-health study had three aims: Aim 1) to define the influence of
psychosocial/cultural factors and biologic mediators as determinants of ethnic disparities
in obesity and MetS in a bi-racial cohort (Whites and AA); Aim II) to define the
effectiveness of patient-centered lifestyle interventions to enhance the health of AAs with
MetS based on community clinical practices; and Aim III) to assess the impact of
innovative lifestyle intervention strategies on conventional and novel biomarkers of
vascular disease risk in AAs.
Baseline Aim II data collected prior to randomization was used for the secondary
analysis in the proposed study. Aim II in the original META-health study focused on
lifestyle interventions related to diet and exercise to improve health outcomes for AA
with MetS. At the baseline visit of the larger study, 203 potential participants were
screened. Screening included an oral glucose tolerance test (OGTT) to identify
participants with undiagnosed impaired glucose tolerance. Participants had to be fasting
for at least 12 hours. Baseline blood draws for plasma glucose were done at fasting, after
which each participant was given 75mg of glucola. Blood draws were done 30 minutes
after the glucola was given and again at 2-hours. Eighty-three participants were excluded
from the study because they did not meet screening criteria based on clinical data related
to fasting glucose, insulin, and cholesterol levels. Participants who successfully
completed a treadmill stress test (no ST-elevations, ischemia or hypertensive response on
baseline EKG) were randomized to the study.
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Incentives
Participants received monetary incentives in the form of gift cards for $25 to $40
depending on the visit. The participants were also compensated for parking or given
tokens for public transportation.
Procedures for Original Study
After obtaining Institutional Review Board (IRB) approval, subjects were referred
through the Community Practitioner Network (CPN) according to HIPAA guidelines.
Potential participants who met inclusion criteria were contacted, screened for eligibility
by phone, and provided with a detailed explanation of the study; the participants who
agreed to participate were invited to a private interview where they completed the
questionnaires. After completing the questionnaires, the participants were randomized to
one of two groups based on a computer generated list of random numbers. The
participants retained the right to discontinue or withdraw participation at
any time.
Participants’ baseline data were collected during a face-to-face interview at two local
clinical research centers. Self-report information on participants’ education level,
income, health history, living arrangements, family health history, and medical history
were obtained. Objective data on participants’ weight and height (without shoes), waist
circumference, and blood pressure were obtained by trained research nurses and study
coordinators. Blood samples were obtained to ascertain clinical values for fasting
glucose, insulin, and cholesterol levels. After the baseline data were collected,
participants were randomized to intervention (education) or usual care, and followed over
a 12-month period. There were four data time-points including baseline, 3-month, 6-
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month, and 12-month. The baseline and 12-month measurements were comprised of two
clinic visits each, one for blood work and one for a treadmill stress test, while the 3month and 6-month measurements had one visit each. Therefore, participants committed
to a total of six clinic visits.
Procedure for the Proposed Study
Since the proposed study was a secondary analysis of existing data from the MetaHealth study, participants were not re-contacted. The baseline data were cleaned and
analyzed based on established statistical methodology.
Sample Criteria
Sample Size for Original Study
A sample size of 306 was proposed for the original study based on established
research data; however, due to challenges in recruiting and after attrition, a sample size of
120 was attained. Both male and female participants, ages 21 to 70 years were recruited
because MetS increases with age, and AA typically report earlier onset of chronic
illnesses which frequently occur at older ages (Grundy et al., 2008).
Sample Size for Proposed Study
Since only data from AA adults ages 45 years and older were examined, the sample
size for the proposed study (n=91) was smaller than the original study (n=120). The data
for 29 participants from the original study were excluded because those participants were
less than 45 years old and therefore not considered middle-aged. Moreover, adults
greater than or equal to 45 years old were considered because the prevalence of MetS
increases with advancing age, and 44% of those over 50 have MetS (Grundy, 2005;
Lechlietner, 2008).
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It is well documented that African American adults typically report earlier onset of
chronic illnesses which frequently occur at older ages, and AA adults have the highest
mortality rates from CHD, a primary outcome of uncontrolled MetS, than any other
ethnic groups or races, especially at younger ages (Clark & El-Etat, 2009; Grundy et al.,
2005).
Recruitment for the Original Study
After receiving approval from the Emory University Institutional Review Board
(IRB), the study staff posted flyers across several large metropolitan university campuses,
including historically black campuses, church bulletin boards, and assisted living
facilities. In addition, the participants were recruited from the Community practice
network (CPN), a practice-based consortium designed to eliminate disparities in
healthcare. The CPN consists of over 40 clinical practices with over 300,000 patient
visits throughout metropolitan Atlanta.
Over a three year period, participants were recruited from health fairs, large
university campuses including historically Black college campuses with over 50% AA
traditional and non-traditional students enrolled and over 80% minority faculty, and
several AA churches in the metropolitan Atlanta area that have a large diverse ethnic
population. Moreover, the targeted health fairs catered to the needs of persons who are
predominantly AA, and the targeted AA churches served a predominantly AA
congregation of various ages. Each AA church had a published congregation of over 700
members with over 60% of the membership aged 50 years or older.
Therefore, it was expected that a representative sample of AA would be recruited in the
various settings, thus reducing threats to external validity.
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Inclusion Criteria for Original Study
The participants self-identified as African American, were able to read, write, and
speak English, were 21-70 years of age, and were required to be diagnosed with
hypertension in addition to two of the six components of MetS [1) waist circumference
greater than 102 cm in men and 88 cm in women; 2) body mass index (BMI) > 25 and <
60; 3) serum triglyceride level of at least 1.7 mmol/L (≥ 150 mg/dl); 4) high density
lipoprotein (HDL) cholesterol level < 40mg/dl in men and < 50 mg/dl in women; 5)
blood pressure (BP) of at least 130 mmHg systolic or 85 mmHg diastolic and 6) fasting
plasma glucose level greater than 110 mg/dl and less than 130 mg/dl].
Inclusion Criteria for Proposed Study
The participants self-identified as African American, were able to read, write, and
speak English, were 45-70 years of age, and were diagnosed with three of the six
components of MetS [1) waist circumference greater than 102 cm in men and 88 cm in
women; 2) body mass index (BMI) > 25; 3) serum triglyceride level of at least 1.7
mmol/L (≥ 150 mg/dl); 4) high density lipoprotein (HDL) cholesterol level < 40mg/dl in
men and < 50 mg/dl in women; 5) blood pressure (BP) of at least 130 mmHg systolic or
85 mmHg diastolic; and, 6) fasting plasma glucose level greater than 110 mg/dl and less
than 130 mg/dl].
Exclusion Criteria for Original and Proposed Study
Exclusion criteria included pregnancy, psychoses, recent abdominal surgery,
cardiovascular interventions or history of myocardial infarction. Although MetS is found
in children, self-management behaviors related to medication adherence are
developmentally linked. Children were not included in the original study because they
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lack the cognitive and developmental capability to self-administer medications and
understand complex medical regimens and more effort would be required to include
children.
Although the Third National Health and Nutrition Examination Survey (NHANES
III) data indicated that 25% of the US adult population 20 years and older and up to 44%
of those over 50 years meet the diagnostic criteria for MetS (Grundy et al., 2008),
participants older than 70 years were excluded because they were more likely to have
other chronic illnesses or experience cognitive deficits or visual changes that may impact
their ability to complete questionnaires. Participants with a current diagnosis of clinical
depression or mental illness were excluded from this study, as these diagnoses may affect
participants’ ability to provide informed consent, complete questionnaires, or take
medications without supervision. Therefore, potential participants with vision
impairments, terminal illnesses, or depression and psychosis as determined by health
history and current medication regimen were excluded from the study.
Data Collection for Original Study
Self-report survey data and clinical measures were used to address questions
related to the problem of hypertension medication non-adherence in a population of AAs
with MetS. Before the baseline visit, each participant self-reported being diagnosed
by a physician with high blood pressure and high cholesterol. In addition, each
participant reported being on a prescription medication regimen for at least three months.
Although the diagnosis of MetS remains controversial, MetS was diagnosed
according to NCEP/ATP III diagnostic criteria. At the baseline visit, the investigator
obtained anthropometrics by measuring participants’ waist circumference and verifying
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participants’ heights and weights in order to calculate body mass index (BMI) (weight in
kilograms divided by height in meters squared) (Third Report of NCEP, 2002).
First, the research staff used a stadiometer with calibrated scale to obtain height and
weight of each participant without shoes. A flexible measuring tape was used to measure
waist circumference and hip to waist ratio. Demographic data and information about
medications and participants’ overall rating of health were obtained through the health
history form. Demographic/clinical variables consisted of age, gender, marital status,
living arrangements, income, education, and co-morbidities. A medication sheet captured
medication use according to past and current use of prescription and non-prescription
medications including anti-hypertensives and lipid-lowering medications.
The participants committed to at least three hours for the baseline visit. Participants
had an hour and a half down time while they waited for the final OGTT blood draw (two
hours after the fasting blood draw). The questionnaires were usually completed during
this down time. Each questionnaire was administered in approximately 5-10 minutes.
Each participant was offered a brief respite and resumed completing the questionnaires
when they indicated they were ready to do so. The participants retained the right to
withdraw from the study at any time and did not lose any benefits if they withdrew from
the study.
Assessment Tools for Proposed Study
The variables and instruments used for the study were: 1) hypertension medication
adherence - Hill Bone Compliance Scale; 2) depression - Beck Depression Inventory II
(BDI-II), 3) stress - Perceived Stress Scale (PSS), 4) provider and patient relationship Health Care Climate Questionnaire (HCCQ); 5) complexity of medical regimen -
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Medication sheet, 6) health literacy - Rapid Estimate of Adult Literacy in Medicine
(REALM); 7) social support – Enhanced Social Support Inventory (ESSI); and 8)
demographic information - Demographic /health history questionnaire.
Hypertension Medication Adherence (Hill Bone Compliance Scale)
Hypertension medication adherence was measured using the Hill Bone Compliance
Questionnaire (Appendix A). Medication adherence conceptually meant following the
medication regimen as prescribed by the physician. Operationally hypertension
medication adherence meant taking the prescribed number of medicine doses at the
frequency prescribed by healthcare provider and refilling medications as ordered. In this
study, medication adherence only focused on adherence to hypertension medications
associated with MetS.
The medication-taking sub-scale of the Hill Bone Compliance Questionnaire was
used to measure hypertension medication adherence (Kim, Hill, Bone & Devine, 2000).
Adequate reliability has been reported for the Hill Bone compliance scale (Cronbach’s
alpha .74 – .84), and adequate construct and predictive validity were established in one
study (Kim et al., 2000). There were no reported reliability and validity for the
individual subscales. For the current study, Cronbach’s alpha was .71.
The original Hill Bone scale consists of 14 items with subscales that measure the
frequency of behaviors related to medication taking (9 items, possible scores of 0 - 18);
appointment keeping (2 items, possible score of 0 - 4), and salt intake (3 items, possible
score of 0 - 6). For purposes of this study, only the hypertension medication adherence
subscale was used. Three possible responses categories for the 9-item medication taking
subscale were used and these response categories score from 0 to 2 for each item (0=
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none of the time, 1= some of the time, and 2 = all of the time). Total scale scores ranged
from 0 to 18, with higher scores indicating less hypertension medication adherence.
Depression (Beck Depression Inventory II)
Depression was measured using the Beck Depression Inventory II (Appendix B).
Depression, the fourth leading cause of early death and disease burden worldwide, has
complex etiology. Clinical depression may be caused by both genetic and non-genetic
factors. The Beck Depression Inventory-II (BDI-II) is a self-administered 21-item scale
(Beck, Steer, & Brown, 1996). Higher scores indicated more depressive symptoms and
item nine captured suicidal ideation. If participants’ BDI scores were > 20 or if they
scored ≥ 2 on item nine, they were immediately referred to a licensed mental health
professional. The BDI-II has adequate validity and reliability, has acceptable sensitivity
and specificity relating to Diagnostic and Statistical Manual (DSM) criteria for major
depression, and also provides a continuum of depressive symptoms (Beck et al., 1996).
The BDI-II has been used in many CHD studies (Beck et al., 1996). For the current
study, the Cronbach’s alpha was .91.
Stress (Perceived Stress Scale)
Psychological stress was measured with the Cohen’s Perceived Stress Scale (PSS)
(Appendix C) (Cohen, Kamarck, & Mermelstein, 1983). The PSS is a widely used
psychological instrument for measuring the perception of stress. It measures the degree
to which situations in one’s life are appraised as stressful. The scale measures the levels
of stress experienced in addition to how overwhelming respondents find their lives.
Higher PSS scores are associated with greater vulnerability to depressive symptoms as a
result of stressful life-events (Cohen et al, 1983). The PSS is a 10-item survey validated
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in multi-ethnic populations with a reliability of coefficient alpha of 0.86. For the current
study, the alpha was .89. PSS scores are obtained by reversing responses (e.g. 0 = 4, 1 =
3, 2 = 2, 3 = 1, and 4 = 0) to the four positively stated items (items 4, 5, 7, and 8) and
then responses are summed across all scale items. Possible range of scores are 0-40 and
higher scores indicate more perceived stress.
Physician-Client Relationship (Health Care Climate Questionnaire)
The quality of the therapeutic relationship between patient and client was
assessed with the Health Care Climate Questionnaire (HCCQ) (Williams, 1998).
The conceptual definition was the quality of the therapeutic relationship between doctor
and patient, and operationally, it was the degree of autonomy and satisfaction the patient
experienced with the healthcare provider.
The HCCQ (Appendix D) was developed to assess the level of autonomy experienced
by the patient and supportiveness of the healthcare climate (HCC) created by the
healthcare staff with their patients; it has been adapted for use in numerous settings. The
HCCQ was validated in a study of patients visiting their primary care physician and was
first used in a study of obese patients. The instrument displays adequate validity and
reliability and is easily administered in various settings. Alpha reliability has been
consistently above 0.90 (Williams, 1998). For the current study, the Cronbach’s alpha
was .95.
The original questionnaire is a 15-item measure that assesses patient’s perceptions of
their satisfaction with their healthcare provider and whether the physician-patient
relationship is conducive to healthy behavior. Responses are structured in a 7-point
Likert-format. The original HCCQ has been modified to a short 7-item scale where
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responses are summed, and higher scores indicate a more therapeutic relationship with
healthcare providers. The range of scores is 0- 42. The mean scores are reported. The
short HCC scale demonstrated adequate reliability of 0.90 (Williams, 1998). The
strength of the instrument is that it was validated in a population of
obese patients and was well suited to this study population. The instrument is easily
administered in a variety of settings.
Complexity of Medication Regimen (Medication Sheet)
Complexity of medication regimen was obtained from the information in the
medication sheet (Appendix E). The medication sheet provided information on the
number of prescription and non-prescription medications, as well as the dosing schedule.
Constitutionally, complexity of the medication regimen was defined as the difficulty or
challenge posed by the medical regimen in terms of multiple dosing frequencies of
medications and multiple medications. Operationally, complexity was defined as the
number of prescription medications and number of doses (Banning, 2009; McDonald,
Pezzin, Peng & Feldman, 2009). The complexity of the medication regimen was
dichotomously coded as “1” for complex regimen (more than one prescription medication
and more than one dose) and “0” for simple regimen (one prescription medication and a
single dose of the prescription medication).
Health Literacy (Rapid Estimate of Adult Literacy in Medicine)
Health literacy (HL) was measured by the Rapid Estimate of Adult Literacy in
Medicine (REALM) questionnaire (Davis et al., 1991) (See Appendix F).
Constitutionally, health literacy was defined as the ability to understand health
instructions in a way to take charge of one’s health. Operationally, HL was the ability to

73
read and understand health instructions and lay terms encountered in a medical setting.
The REALM is a screening instrument used to assess an adult patient’s ability to
read words, such as lay terms for body parts and illnesses frequently encountered in a
medical setting (Davis et al., 1991). The REALM was originally validated in 207
primary care patients and field tested with 203 adult patients in four public hospital
primary care clinics. Adequate reliability (0.84) for the REALM has been reported
(Davis et al., 1991). The REALM has been correlated with other
standardized tests of health literacy and reading comprehension; the REALM is highly
correlated with the Wide Range of Assessment Test-Revised (WRAT-R) (r =0.88), the
revised Slosson Oral Reading Tests (SORT-R) (r = 0.96), and the test of Functional
Health Literacy in Adults (TOFHLA) (0.84). The REALM demonstrated concurrent
validity with the TOFHLA with a correlation coefficient of 0.84 (p < .001). Test-retest
reliability was high (coefficient 0.99) for the REALM in a sample of 100 adult inmates
(Davis et al., 1991).
The possible range of scores was 0-66. Score cut-offs were to be included based on
the identified scoring categories. The number of correct words in the list was counted,
and the number was then recorded as the raw score. The total raw score was then
matched with its grade equivalent (Davis et al., 1991). For example, scores ≥ than 60
were coded as ≥ high school reading level, and scores < 60 were coded as < high school
reading level. Score cut-offs were included: middle-aged AA with raw scores of 0-18
were counted as third grade reading level; scores of 19-44 were equated to fourth to sixth
grade reading level; and scores of 45-60 were equated to seventh to eighth grade reading
levels. Reading equivalency level of high school or greater (score of ≥ 61out of a
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possible 66) indicated that an individual should read and understand most healthcare
information, since healthcare information is commonly written at tenth grade reading
level (Safeer & Keenan, 2005). For analysis, scores were dichotomized as
scores < 60 = 0 (inadequate HL), and scores ≥ 60 = 1 (adequate HL) (Davis et al., 1991).
The REALM is one of the best word recognition tests and is still widely used
today to assess patients’ HL. The strength of the REALM for this study was its time and
ease of administration in various settings and across diverse populations. Moreover,
researchers do not need to be trained before they administer the REALM. The instrument
only takes about two minutes to administer.
Social Support (Enrichd Social Support Scale)
Social support was measured using the Enrichd Social Support Inventory (ESSI)
(Appendix A). Constitutionally, Haslam et al. (2006) define social support (SS) as
interpersonal transactions that provide individuals with esteem, stress-related aid and
emotional assistance. Operationally, social support is the degree of emotional and verbal
encouragement from one’s social network such as family, friends, and co-workers.
The ESSI was developed for a study called Enhancing Recovery in Coronary
Heart Disease (ENRICHD) (Berkman et al., 2003). Internal consistency for the ESSI was
found to be adequate (Cronbach’s alpha of 0.86-0.88) (Vaglio et al., 2004). For the
current study, the alpha was .87. The ESSI correlated strongly and significantly with the
Perceived Social Support Scale (PSSS) (r = .63, p < .0001). Concurrent and predictive
validity were established using the SF-36 and the Seattle Angina Questionnaire (SAQ)
Quality of Life (QOL) scale at baseline and 6 months in patients undergoing
percutaneous coronary intervention (PCI) (Vaglio et al., 2004). The ESSI and the SF-36
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Social Functioning subscale, the SF-36 Physical and Mental Component scores correlated
modestly (r =0.19, p= 0.002). The ESSI consists of seven statements of social and
emotional support with responses in a 5-point Likert format. The categories range from 1
(none of the time) to 5 (all of the time) for the first 6 items and item seven (living with
spouse) scored 4 for “yes” and 2 for “no.” Individual items were summed for a total
score, with higher scores indicating greater social support. The range of scores is from 834. Items elicit information on the availability of someone to provide structural support,
emotional (caring) support, informational support, and instrumental social support. The
social support variable was interval level of measurement.
Data Analysis for Proposed Study
Data were analyzed using the Statistical Analysis Software (SAS) application
version 9.0. Frequencies were run for all study variables before specific analyses were
conducted. Descriptive statistics including measures of central tendency and
variability such as the mean and standard deviation, for sample characteristics and main
variables of interest were reported. . The extent of missing data were estimated and
handled by imputation based on the valid values of other cases or variables in the
sample. Thus, a group mean was inserted for the missing values by mean
item substitutions.
The types of analyses were dependent on the level of data (nominal or continuous).
Each variable of interest for this study was examined for its univariate distribution and to
identify outliers for those variables measured on a continuous scale. Therefore, data were
examined for normality. Each variable was analyzed for normal distribution in an initial
data screening based on histogram, skewness, extent of kurtosis, box plots and tests for
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outliers in order to determine whether parametric or non-parametric testing was
appropriate. Cut-off points for outliers were determined using three standard deviations
above or below the mean as criterion. Bivariate correlation was assessed to identify
highly correlated variables that may have caused collinearity problems in multiple
regressions. Correlational analysis was used to examine relationships between key
variables as appropriate. Measures of central tendency were used to describe the sample
in terms of age (mean and range), height, weight, BMI, gender, complexity of medication
regimen, and co-morbidities. The dependent variable (DV) was hypertension medication
adherence and the independent variables (IV) were social support, stress, depression,
complexity of medication regimen, quality of the therapeutic relationship, and health
literacy.
For Research Question 1: “What is the relationship of personal factors (age,
gender, income, depression, co-morbidities, and education), behavioral capability
(health literacy), and medication adherence in AA adults with MetS?” Chi square
analyses were used to examine the relationships between key variables after categorizing
participants based on meaningful cut-points for each variable.
For Research Question 2: “What is the relationship between environmental
factors (stress and social support), barriers (complexity of the medication regimen, and
non-therapeutic health care climate), and medication adherence in AA adults with
MetS?” Chi square analysis was used to analyze data after categorizing the
participants based on meaningful cut-points for each variable.
Logistic regression was used to answer Research Question 3: “Will
age, gender, income, education, health literacy, complexity of the medication regimen,
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and quality of the therapeutic relationship explain a greater variance in medication
adherence over and above social support, stress, and depression in AA adults with
MetS?”
For Research Question 4: “Will AA adults with adequate behavioral capability
(health literacy) report greater medication adherence than those with inadequate
behavioral capability (health literacy)?” Independent samples t-tests were used to
compare mean scores on medication adherence between the participants with high
functional health literacy (REALM scores greater than or equal to 61 out of a possible 66
score) and those who had low functional health literacy (REALM scores less than 61 out
of a possible 66 score).
Human Subject Consideration
The META-health study is a multi-site collaboration with investigators from Georgia
State University, Dr. Pat Clark; Emory University, Dr. Sandi Dunbar; Dr. Arshed
Quyyumi and Dr. Viola Vaccarino, Emory University; Dr. Gary Gibbons and Dr.
Priscilla Pemu, Morehouse School of Medicine. IRB approval was obtained prior to
analysis of existing data.
Risks
For the proposed study there were no interactions between the student researcher and
the participants because participants were not re-contacted for the secondary analysis.
Confidentiality
Participant confidentiality was maintained by keeping personal information private.
The consent forms were stored in separate locked file cabinets away from the other study
data which were also stored in locked file cabinets. A study number rather than
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participant name was used on the original study records. Data from the original
study as well as the current study were stored on firewall- and password-protected
computers.
Summary
While research on health literacy and hypertension medication adherence is limited,
the current research fails to address the topic from the perspective of middle-aged AA
with MetS. The study presented a unique opportunity to address gaps in the literature to
gain a fuller understanding of the relationship between personal and environmental
factors and hypertension medication adherence in a cohort of middle-aged AA with
MetS. A huge body of literature shows that nearly half of American adults have
difficulty understanding health information in a way to take charge of their health. In
particular, older AA report disparately high rates of low functional health literacy, even
higher rates of medication non-adherence, and disparately high rates of chronic illnesses
for which prescription medications are the primary therapeutic regimen. It is wellestablished that health literacy is a priority area for self-management for adults with
chronic illnesses who take multiple medications to prevent negative health outcomes.
Study findings may provide a deeper understanding of the correlation between study
variables and medication adherence in AA adults with MetS. Identifying factors which
are associated with low hypertension MA, which may lead to negative healthcare
outcomes for AAs with MetS, will allow healthcare providers to identify AAs at risk
early.
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Chapter IV
Results
Data were analyzed using the Statistical Analysis Software (SAS) software
application version 9.0. Descriptive statistics were calculated, including measures of
central tendency and variability such as the mean and standard deviation, for sample
characteristics and main variables of interest. The dependent variable was hypertension
medication adherence and the independent variables were personal factors (age, gender,
income, co-morbidities, depression), behavioral capability (health literacy),
environmental factors (stress, social support), and barriers (health care climate, and
complexity of the medical regimen). Reliability was assessed for all instruments using
Cronbach’s alpha for scales as appropriate and reported in Table 4.
The personal characteristic and environmental factor variables such as age, gender,
income, depression, stress, social support, health care climate, and education were
originally collected in a continuous format. However, based on distributional properties,
it was decided to dichotomize the variables, thus making Chi-square and logistic
regression the most appropriate analysis methods.
The sample size of 91 was large enough to provide a minimum power of .80
with alpha of .05 for the multiple regression with ten independent variables (k) (Research
Question 3). Warner (2008) recommends a minimum of N > 50 + 8k or N > 104 + k to
identify significant independent predictors. However, several variables were found to
have non-normal distributions and were therefore converted to categorical variables,
including

the

primary

outcome

variable,

medication

adherence,

which

was

dichotomously coded (adherent was coded with “1”; not adherent was coded“0”).
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Therefore, logistic regression was used to answer this question.
For Research Question 1, “What is the relationship of personal factors (age,
gender, income, depression, co-morbidities, and education), behavioral capability
(health literacy), and medication adherence in AA adults with MetS?”
Chi-square analysis was used to answer this research question because it allowed for
meaningful comparisons about how groups such as males and females, low income and
high income, and high school reading equivalency and less than high school reading
equivalency, differed in terms of proportions reporting hypertension medication
adherence and non-adherence.
Although it is often better to use variables in a continuous format, the
categorization of continuous variables in this case was based on the distributional
properties of the variables and the categories used still provided for meaningful
comparisons. For example, although age was continuous data, the variable was dummy
coded to categorize those over 50 years old and those less than 50 years old. The
research suggests that adults over 50 years old are less likely to report MA (Gazamararian
et al., 2000). Moreover, the risk for MetS increases significantly in adults over 50 years
old compared to those less than 50 years old (Grundy et al., 2004; Lechlietner, 2008).
Consistent with the literature using 14 as the standard cutoff, depression scores were
dichotomized into no depressive symptoms (< 14) or elevated depressive symptoms (≥
14) (Berkman et al, 2003).
For Research Question 2: “What is the relationship between environmental
factors (stress and social support), barriers (complexity of the medication regimen, and
non-therapeutic health care climate), and medication adherence in AA adults with
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MetS?” Chi square statistics were used to examine these relationships. Chi square
analysis was most appropriate because the decision was made to categorize
continuous variables after inspection of their distributions. Reference groups included
those with more complex regimens compared to those with simple regimens, and those
who reported more autonomy or satisfaction with their healthcare climate (HCC) (HCC
score of >3) compared to those with less satisfaction with their health care climate (score
of ≤ 3) and the proportions of each group that reported greater medication adherence
(score of < 10).
The original plan was to use multiple hierarchical regression to answer Research
Question 3: “Will age, gender, income, education, health literacy, complexity of the
medication regimen, and quality of the therapeutic relationship explain a greater
variance in medication adherence over and above social support, stress, and depression
in AA adults with MetS?” However, due to non-normal distribution of several variables
including the outcome variable, logistic regression was used to address this question.
For Research Question 4: “Will AA adults with adequate behavioral capability
(health literacy) report greater medication adherence than those with inadequate
behavioral capability (health literacy)?” The non-parametric counterpart of the
independent samples t-test, the Wilcoxon rank sum test was used to compare ranks on
hypertension medication adherence between the participants with high functional health
literacy (REALM scores greater than or equal to 61) and those who had low functional
health literacy (REALM scores less than 61).
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Descriptive Statistics of Sample
Demographic Information
In the cohort of AA adults with MetS (N=91), 72 were female (79%) while 19
were male (21%). Participants ranged in age from 45 to 70 years, with an average age of
53.2 (SD = 6.3) years. Nine participants (10%) reported attaining a high school education
or General Educational Development (GED) Certificate, while 63 participants (69%)
reported acquiring some college education. The participants reported various household
income levels; a few (13%) reported low income (< $19,000); several (25%) reported
incomes in the range of $40,000-60,000, while others (13%) had incomes above $60,000
and $80,000. Table 1 provides further categorization of demographic variables.
Table 1
Descriptive Statistics of Sample Characteristics
Variables

n(%)

Age
45-50 years old
> years old

30 (33)
61 (67)

Gender
Male
Female

19 (21)
72 (79)
91 (100)

Education
High School/GED
Technical School (vocational school)
College

9 (10)
17 (19)
63 (69)
89 (98)

(Table 1 Continues)
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(Table 1 Continued)
Variables

n(%)

Household Income
<$19,999
$20,000 - $39,999
$40,000 - $59,999
$60,000 - $79,000
> $80,000
Don’t know
Prefer not to answer

12 (13)
22 (24)
21(23)
12 (13)
12 (13)
3 (3)
8 (9)
90 (99)

Marital Status
Married
Divorced
Separated
Widowed
Single

37 (41)
21 (23)
3 (3)
9 (10)
20 (22)
90 (99)

Clinical Characteristics
Over half (n = 46) presented with uncontrolled high blood pressure (BP ≥
130/80), while 12% (n=11) presented with dyslipidemia. The mean systolic BP was 127
mm Hg; the mean diastolic BP was 79 mm Hg (SD 6.3). Other clinical characteristics are
shown in Table 2.
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Table 2
Clinical Variables for Sample and by Gender
Male
n=19 (21%)
B/P > 130.80
Fasting Glucose
<100 mg/dl
100-125 mg mg/dl
> 126 mg/dl

Female
n=72 (79%)

Total sample
n=91

9 (48)

37 (52)

46 (50.5)**

12 (63)
4 (21)
3 (16)
19 (100)

29 (40.3)
42 (58.3)
1 (1.4)
72 (100)

41 (45.1)
46 (50.5)
2 (2.2)
89 (98)

3 (15.8)
16 (84.2)
19 (100)

5 (7.0)
67 (93.0)
72 (100)

8 (8.8)
83 (91.2)
91 (100)

106.59 (13.52)
121.01 (16.10)

107 (13.82)
120 (14.95)

50.5 (11.8)
117.8 (34.6)

49.6 (11.9)
116.2 (34.3)

BMI (kg/m2) n (%);
25-29.9
> 30

WC M (SD)
HC M (SD)

109.42 (11.52)
114.28 (7.89)

HDL – M (SD)
LDL M (SD)

47.5 (12.8)
109.2 (29.8)

Note: WC = waist circumference, HC = hip circumference.
**The number of participants who presented with uncontrolled BP.
Medication Regimens
Almost three quarters of the sample (74%) reported simple medication regimens,
that is, taking only one prescription medication and single dosing, while the remainder
(26%) reported combination therapy or complex medication regimens of taking two or
more prescription medications with multiple dosing. The majority of the participants
(71%) took their hypertension prescription medications once daily and the others (29%)
took prescription medications twice or more daily (see Table 3). The most frequently
used hypertension medications were diuretics (74%), calcium channel blockers (28%),
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angiotensin converting enzyme (ACE) inhibitors (22%), angiotensin receptor blockers
(ARBs) (15%), and beta-blockers (15%).
Table 3
Complexity of Medication Regimen and Medication Classification
Number of Agents
Monotherapy
Dual therapy
Triple therapy

Total – n (%)
67 (74)
21 (23)
3 (3)

Number of doses – n (%)
One dose
More than one dose

67 (74)
24 (26)

Medication classification

ACE/ARB – n (%)
Diuretic
β-Blocker –
Calcium Channel Blocker

34 (36)
67 (74)
14 (15)
26(29)

Note: Complex regimen = dual or triple therapy and/or multiple dosing; Simple regimen
= monotherapy and/or single dosing.
Descriptive Statistics for Major Study Variables
Descriptive statistics and adequate reliability coefficients for the major study
variables are shown as appropriate in Table 4. Higher scores indicate greater levels of the
variable, except for medication adherence, where higher scores indicate less hypertension
medication adherence. Most (83%) of the sample reported low depressive symptoms,
94% reported low stress, 95% reported adequate HL, 85% reported adequate social
support, while 94% reported satisfaction with HCC.
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Table 4
Descriptive Statistics and Reliability Coefficients for Major Study Variables (N = 91)
Variables

Observed
Min/Max

Potential
Min/Max

Cronbach’s
Alpha

7.64 (7.3)

2-43

0-63

.91

15.08 (7.34)

9-33

0-40

.89

63.00 (3.31)

40-66

0-66

n/a

5.04 (1.16)

5-6

0-6

.95

ESSI: Test of
Social Support

26.00 (6.05)

23-32

2-40

.87

Hill Bone: Test
of hypertension
medication
adherence

11.5 (2.56)

9-18

9-36

.71

BDI-II: Test of
depressive
symptomatology

PSS: Test of
perceived stress
REALM: Test
of reading
recognition
HCC: Test of
autonomy and
satisfaction with
health care
climate

M(SD)

Note: Min = minimum; Max = maximum.

Health Literacy
The mean score on the REALM was 63.67 (SD=3.31) indicating that on average
participants displayed greater than a high school reading level (REALM score ≥ 61). Of
the 87 participants who reported a high school degree or higher, four had less than a high
school reading level according to the REALM classification. The range of scores was
40-66; therefore the reading equivalency levels ranged from third grade (1%) to high
school or greater (94%).
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Hypertension Medication Adherence
Participants’ scores on the hypertension medication-taking subscale of the Hill
Bone Compliance scale ranged from 9-18 out of a possible range of 9-36. Thus, overall
the mean was low (11.5, SD= 2.6) indicating relatively good hypertension medication
adherence. However, based on the strict ranges for scoring the Hill Bone Compliance
subscale (adherent = a score of 9, non-adherent= score of ≥ 10), nearly one-third (30%)
of the participants were not adherent with hypertension medication taking (Kim et al.,
2000). The scores were dichotomized to facilitate the logistic regression analysis and to
provide more meaningful comparisons of the sample.
Relationship of Hypertension Medication Adherence with Sample Characteristics
Relationships among key variables were explored using chi square analysis. There
was no significant difference in hypertension medication adherence between men and
women [χ2 (1, n = 90) = 0.0096, p = 0.92)].
Research Question 1
Initial data screening indicated that the data were not normally distributed.
Therefore, several of the personal factor variables were dichotomously coded. Chi square
analysis was then used to examine relationships between these key variables.
The categorizations for income were problematic because two of the categories
were “don’t know” and “prefer not to answer’ and so income was not truly ordinal level
data. Chi square analysis allowed for comparisons about how groups such as males and
females, low income and high income, and high school reading equivalency and less than
high school reading equivalency, differed in terms of proportions reporting medication
adherence and non-adherence.
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Therefore, Chi-square analysis was used to answer Research Question 1: “What is
the relationship of personal factors (age, gender, income, depression, co-morbidities, and
education), behavioral capability (health literacy), and medication adherence in AA
adults with MetS?” to allow for more meaningful comparisons because gender, income,
and education were nominal and ordinal levels of measurement.
The results indicated that older (≥ 50 years old) participants were less likely to
report hypertension medication adherence [χ2 (1, n = 90) = 6.71, p = 0.0096)] than
younger ones (< 50 years old). However there were no other significant relationships
between personal factors, behavioral capability and hypertension medication adherence
as shown in Table 5.
Table 5
Comparison of Personal Factors and Hypertension Medication Adherence
Variable

DF

Age (> 50 years)

1

Gender (0=male,
1=female)

1

Education (HS or
greater reading
level)

1

Low Income
(<$19,999)

1

Depression (score of
>14)

1

Chi-square

6.71

.0014

Probability

.0096

.9704

2.11

.6461

1.16

.2816

.1739

.6767
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Results indicated that Research Question 1 was only partially supported as there
was only one significant relationship, that of age and hypertension medication adherence
[χ2 (1, n = 90) = 6.71, p = 0.0096)]. Middle-aged African Americans with MetS (≥ 50
years) were more likely to report less hypertension medication adherence than those < 50
years old.
Co-morbidities
Table 6
Participants (N = 91) Co-morbidities and Inclusion Components
Variable

Co-mordibities:

N (%)

M/SD

91 (100)

1.20 (0.3)

High BP (> 130/80 mmHg)

46 (51)

127/79 (6.3)

Impaired Fasting Glucose (IFG)
(FPG >100 mg/dl)

46 (53)

95.8 (15.5)

LDL cholesterol (> 126 mg/dl)

11 (12.0)

116.2 (34.3)

HDL cholesterol (<50 mg/dl)

12 (13.0)

49.6 (11.9)

Triglycerides (>150 mg/dl)

12 (13.0)

133.2 (90.0)

(Table 6 Continues)
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(Table 6 Continued)
Variable

N (%)

M(SD)

Total cholesterol (>200 mg/dl)

12 (13)

193 (37)

Obesity (BMI >30kg/m2)

83 (91)

36.5 (6)

Waist Circumference

80 (89)

107.2 (13.8)

Note: B/P = blood pressure. BMI = body mass index. HDL or LDL = high or low
density lipoprotein.
The co-morbidities listed above (Table 6) were part of the metabolic syndrome,
thus they are not typical Charlston co-morbidities but were components of the inclusion
criteria. Given that hypertension MA was the outcome measure, hypertension was
excluded while the other co-morbidities were counted for each person. The number of
co-morbidities was analyzed to see if there was an association with hypertension
medication adherence. Table 6 provides additional descriptions of sample comorbidities. Of the 91 participants more than half (51%) presented with uncontrolled
high blood pressure (>130/80 mm Hg). Although two participants (3%) reported a
history of diabetes (fasting glucose levels >125 mg/dl), over half of the sample (53%)
presented with impaired fasting glucose levels (fasting plasma glucose levels > 100
mg/dl) despite having no known history of diabetes. Moreover, several participants had
elevated lipoprotein levels but were not on lipid-lowering medications. On average,
women had HDL levels at the low end of the acceptable range of <50 mg/dl, while men
on average were slightly above the 40 mg/dl acceptable range for men. Most participants
(91%) were obese (BMI >30 kg/m2). Because of the small numbers of participants who
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fell in the diabetes, overweight class, and dyslipidemia categories, it was not meaningful
to conduct further analyses for co-morbidities.
Research Question 2
To answer Research Question 2: “What is the relationship between environmental
factors (stress and social support), barriers (complexity of the medication regimen, and
non-therapeutic health care climate), and medication adherence in AA adults with MetS
?”, Chi-square analysis was used to compare groups based on cut-off scores. Chi square
analysis allowed for comparisons about how groups such as low stress and high stress,
low social support and high social support, complex and simple regimens, and therapeutic
and non-therapeutic healthcare climate differed in terms of proportions reporting
medication adherence and non-adherence. Among the environmental factors and
barriers, stress [χ2 (1, n = 90) = 6.28, p = .012)] and social support [χ2 (1, n = 90) = 4.10,
p = .04)] had the only significant relationships with hypertension medication adherence.
Therefore the research question was only partially answered. Table 7 provides further
comparisons of variables to hypertension medication adherence.
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Table 7
Comparison of Stress, Social Support, Health Care Climate, Complexity of Regimen, and
Hypertension Medication Adherence
Variable

Adherence

Chi-square

Probability

N (%)

Low Stress (n=85)

A 60 (70)
NA 25 (30)

4.62

0.03

Adequate Social support
(n=77)

A 54 (70)
NA 23 (30)

4.10

0.04

Simple Regimen
(n=67)

A 60 (90)
NA 7 (10)

1.21

0.27

Good HCC
A 73 (85)
2.46
(n=86)
NA 13 (15)
Note: HCC – Health Care Climate; A = Adherent; NA = Non-adherent

0.12

Research Question 3
Logistic regression was used to answer Research Question 3: “Will age,
gender, income, education, health literacy, complexity of the medication regimen, and
quality of the therapeutic relationship explain a greater variance in medication
adherence over and above social support, stress, and depression in AA adults with
MetS?”
Since the dependent variable was dichotomized to reflect adherence and nonadherence (1= adherent versus 0 = not adherent) logistic regression analysis was
appropriate. Moreover, the dependent variable (MA) was dichotomous (1= adherent
versus 0 = not adherent). The goal of the regression was to determine if a certain group
of independent predictors were able to predict non-adherence.
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In comparing adults with high stress and those with low stress (OR=0.848, 95%
confidence interval .731-.983, p =.0291), highly stressed adults had a 15% reduction in
the odds of adherence. Similarly, adults with a low income were 5.8 times more likely to
be non-adherent (OR 5.828, 95% confidence interval 1.014-33.493, p= .0482). While
adults with low social support had a 9% reduction in the odds of adherence, social
support trended to significance (OR .914. 95% confidence interval .823-1.016, p =.09).
African Americans of older age were more likely to be non-adherent (OR 1.12, 95%
confidence interval 1.028-1.220, p=.0096), indicating that older AA with MetS were 12%
more likely to be non-adherent with their hypertension medication regimens. The Wald
statistic is the value tested for significance in logistic regression to determine which
variables affect the probability of an event. In this analysis, the Wald was not significant.
Thus, depression and social support were not significant predictors of hypertension
medication adherence over and above the other predictors. In fact, age was more
significant than stress, social support, or depression. Therefore, partial support was
provided for the research question.
Research Question 4
Medication Adherence and Health Literacy
Research Question 4: “Will AA adults with adequate behavioral capability (health
literacy) report greater medication adherence than those with inadequate behavioral
capability (health literacy)?” Because the adherence variables were not normally
distributed, Wilcoxon rank sum test was used to compare mean rank scores on
medication adherence between the participants with high functional health literacy
(REALM scores greater than or equal to 61) and those who had low functional health
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literacy (REALM scores less than 61).
Of the 91 participants, most of the sample (95%) had attained health literacy
levels equivalent to high school or greater. These reading equivalencies corresponded to
REALM scores of 61 or greater out of a maximum score of 66. Given that 95% of the
sample reported adequate health literacy, the comparison of health literacy groups should
be interpreted with considerable caution. Results from the Wilcoxon rank sum test for
independent samples was not significant (p= 0.6192). For those with higher HL (n = 87),
the median MA score was 11, range of 9-13 compared to those with low HL (n=4) who
had a median score of 10, range of 10-18 (z =139.5, p = 0.619).
Summary
The sample (N=91) was primarily female, middle aged, [M 53.2 years (SD 6.3)],
relatively well-educated, and married, with variability in household income (< $19, 000
to over $80,000). Most participants presented with uncontrolled high blood pressures and
reported several co-morbidities including obesity, elevated fasting glucose levels, and
dyslipidemia. In addition, almost a quarter of the sample reported elevated lipoprotein
levels. Although the vast majority of the sample displayed adequate health literacy, 30%
of the sample was non-adherent to their hypertension medication regimen because of the
strict scoring for the Hill Bone Scale.
Research Question 1 was addressed. Results indicated that a considerable number
of older (>50 years) African American adults (n= 43, 70%) with MetS were non-adherent
to their hypertension medications. There were no other significant relationships between
personal characteristics, behavioral capability, barriers and environmental factors and
MA.
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Research Question 2 and Question 3 were partially answered. High stressed
middle-aged adults were significantly more likely to be non-adherent or had a 15%
reduction in the odds of hypertension medication adherence. Similarly, middle-aged
adults with a low income were 5.8 times more likely to be non-adherent (OR 5.828, 95%
confidence interval 1.014-33.493, p = .0482), while middle-aged adults with low social
support had a 9% reduction in the odds of hypertension medication adherence; social
support trended to significance (OR.914, 95% confidence interval .823-1.016, p =.09).
Older AA were more likely to be non-adherent (OR 1.12, 95% confidence interval 1.0281.220, p =.0096) than middle-aged AA adults. Finally, given that 95% of the sample
reported adequate health literacy, the comparison of health literacy groups should be
interpreted with considerable caution.
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Chapter V
Discussion and Conclusion
Uncontrolled hypertension in African Americans (AA) accounts for nearly 8,000
preventable deaths per year from cardiovascular events (Fiscella & Holt, 2008; Gu, Burt,
Paulose-Ram, Yoon, & Gillum, 2008). In fact, AA adults have the highest mortality rate
from cardiovascular disease (CVD) of any ethnic group, and especially at younger ages
(CDC, 2007; Lechlietner, 2008). Moreover, vascular disease and its CVD complications
carry a significant increase in morbidity and mortality in AA compared to their White
counterparts (Anuurad, Chiem, Pearson & Berglund, 2007; Hilgers & Mann, 2008;
Wright et al., 2008). Given that CVD is the largest cause of death (AHA, 2007) and the
primary clinical outcome of MetS (Clark & El-Atat, 2007), it is important that AA adults
with MetS take their hypertension medications as prescribed by their healthcare provider
to prevent worse heath care outcomes as they get older. It is well established that AA
have worse health care outcomes than any other ethnic group. Interventions such as
education about making proper lifestyle choices and appropriate medication-taking may
be beneficial in the long term for this vulnerable population with its history of multiplejeopardy. Moreover, early interventions such as making combination therapy the first
line of defense for AA adults with MetS may aid in halting the cycle of cumulative
disadvantage in old age.
Using baseline data collected from a convenience sample of 91 African Americans
over 44 years old, the investigator found a significant relationship between certain
personal and environmental factors and hypertension medication adherence (MA).
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Personal Characteristics
The literature showed, that in studies which examined self-management behavior,
personal characteristics were found to influence hypertension medication adherence.
These study findings were consistent with the literature. Age was significantly associated
with hypertension medication adherence. The sample was relatively younger (mean age
53 years) than other samples in self-management studies (Benson & Forman, 2002). In
addition, the sample in this study was mostly female (79%), married, obese, and reporting
uncontrolled diastolic and systolic blood pressure. Although the majority of the sample
was recruited from a community practice network, most participants reported relatively
high incomes which have been found to have a positive influence on medication
adherence (Benson & Forman, 2002; Murray et al., 2004). People with higher income
tend to receive healthcare on a more regular basis than those with lower incomes.
It is well-established that older adults with lower income and low education are more
likely to display medication non-adherence (Fiscella & Holt, 2008). Consistent with the
literature (Benson & Forman, 2002), this study sample was middle-aged, relatively welleducated and reported a good income; therefore the majority of the participants (70%)
were adherent with their hypertension medication regimens.
Co-morbidities
MetS is a cluster of metabolic abnormalities including high blood pressure,
dyslipidemia, insulin resistance, and obesity. Yatskar et al. (2007) found that MetS
predicted development of diabetes for patients who did not have diabetes at baseline. In
addition, insulin resistance is present in most people with MetS (Reaven et al., 2002). It
is well documented that older adults diagnosed with MetS frequently display severe co-
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morbidities (Grundy et al., 2008). Moreover, the literature suggests that persons with
severe co-morbidities are more likely to display medication non-adherence (Lagu et al.,
2009). In the current sample, the cluster of MetS risk factors was well-represented;
however, the majority of the participants only reported co-morbidities which were in fact
components of the inclusion criteria. Moreover, despite being on hypertension
medications, more than half of the sample presented with uncontrolled high blood
pressure; more than 10% presented with dyslipidemia; about 25% reported impaired
fasting glucose levels; almost all were obese (BMI >30). Although most participants
reported impaired fasting glucose levels, only a small number of participants (3%) were
diabetic. It would appear that the majority of the participants were unaware of their risk
for diabetes, a negative health care outcome frequently associated with uncontrolled
MetS. Most of the components of the cluster of metabolic abnormalities of MetS were
well represented in this cohort of middle-aged AA with MetS. However, except for
participants in the high blood pressure group, there were only small numbers of
participants with true co-morbidities outside of the components of the inclusion criteria.
In fact, the Charlston co-morbidity index was not used in the larger study so there was no
true measure of co-morbidities in the current study.
In the current study, the majority of the sample was adherent with their
hypertension medication regimens and that behavior may be explained by the fact that the
majority of the sample was primarily on mono-therapy and simple regimens, as well as
reporting good incomes. However, over half of the sample presented with uncontrolled
high blood pressure. This anomaly may be explained by the monotherapy. Although this
sample self-reported HTM medication adherence, the medication regimens did not appear
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to effectively control high blood pressure. The Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
(JNC7) recommends combination therapy as the first line of defense for controlling high
blood pressure in AA. The current study findings are consistent with the literature which
shows that AA are still frequently placed on monotherapy, despite the well-documented
success of combination therapy in controlling high blood pressure in this vulnerable
population (Chobanian et al., 2003; Poon et al., 2009). Healthcare providers need to be
more vigilant in making sure that there is increase in combination therapy for these AA
adults.
Depression
Reynolds et al. (2004) provided evidence that depression was the strongest correlate
of medication non-adherence, and medications to treat chronic illnesses may intensify
depression.
Psychosocial factors such as depression are helpful in explaining and understanding
non-adherence with medication regimens (Bane, Hughes, & McElnay, 2006;
Schoenthaler, Ogedegbe, & Allegrante, 2007). Given that medication non-adherence
may be tied to depression, healthcare providers need to understand the psychosocial
reasons for non-adherent behavior to prevent lapses in the medical regimens. It is well
documented that depression is widely implicated in non-adherent behavior (Bane et al.,
2006).
Williams (1998) found that higher incidences of chronic health, economic strain,
discrimination and disparities in the healthcare delivery system may lead to depression,
which influences medication adherence. It appears that a lack of health insurance or
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inadequate health insurance coverage and the inability to afford costly medications
frequently increases stress which leads to depression.
However, in the current study, the association of depression and medication
adherence was inconclusive given that increasing depressive symptoms were an
exclusion criterion in the larger study. In fact, in the current study most of the sample
was relatively well educated and most reported incomes greater than $40,000, so it was
not surprising that 70 participants (83%) reported no depressive symptoms based on their
socio-economic status (SES). This is not to say that high SES precludes depressive
symptoms. Inferential statistics showed that there was no significant relationship
between depression and hypertension medication adherence. It is notable that due to the
higher BDI cut-off scores (less than 21) for study inclusion compared to lower cut-off
scores (less than15) in other studies (Berkman et al., 2003) for depressive symptoms, the
majority of the sample did not report depressive symptoms.
Behavioral Capability
Health Literacy
In the current study, health literacy was measured using the REALM. The
REALM is a reading recognition test, not a test of reading comprehension, so participants
who attain high school reading level may not always display adequate functional health
literacy or good comprehension of health information (Benson & Forman, 2002).
Additionally, participants with higher education do not always display good reading
recognition as measured by the REALM.
The participants overwhelmingly reported high school reading levels which were
consistent with their educational attainment. Consequently, the results were not
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significant for the analyses comparing those with adequate functional health literacy
(95%) (score of 61 or greater on the REALM) and those with inadequate HL (5%) (score
of 60 or less out of a possible 66 on the REALM). Although the results indicated that the
overwhelming majority of individuals (95%) should easily read and understand most
healthcare information which is written at 10th grade level or greater (Safeer & Keenan,
2005), almost one-third (30%) of the participants were not adherent with their medication
regimens as measured by the Hill Bone medication-taking subscale. This anomaly may
have occurred because of the strict scoring of the Hill Bone Scale; an all or nothing score
(score of 9 indicates adherence, >9 indicates non-adherence; range 9-18). According to
the results from the National Adult Literacy Survey, 22% of US adults function at the
lowest literacy skill level (3rd grade equivalent) (Benson & Forman, 2002). Safeer and
Keenan noted that although most health care materials are written at 10th grade level or
higher, most adults read between the eighth and ninth grade level. These researchers
found that participants with a reading equivalency of at least high school level as
measured by the REALM were able to read most patient education materials.
The sample in this study displayed remarkably high health literacy skills. In fact,
the majority of the participants attained at least high school formal education, and 95% of
the sample achieved good reading recognition on the REALM. Based on these findings,
one would expect that most of the participants in this current sample should be able to
read and understand healthcare information allowing them to take charge of their health.
As expected, 70% of the participants reported adherence to medication taking as
measured by the Hill Bone hypertension medication- taking subscale.
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Georges, Bolton, and Bennett (2004) found that patients with inadequate
functional health literacy had difficulty reading, understanding, and interpreting health
information and medication instructions. In the current study, although the participants
overwhelmingly reported adequate health literacy (95%), no significant relationship
between high health literacy scores and hypertension medication adherence were found
because there was little or no variation in health literacy hindering the ability to find any
relationship. In a study by Benson & Forman (2002) it was found that in a population of
affluent, well-educated older adults, 30% of the participants displayed poor functional
health literacy.
In a related study by Hixon (2004) patients with inadequate functional health
literacy invariably were non-adherent with their medication regimen. Hixon found that
patients without formal education displayed inadequate functional health literacy;
frequently attained less than high school reading levels, and did not know how to take
their medications properly. In the current study, the participants with higher health
literacy were mostly adherent with their regimens but the findings are inconclusive given
that the majority of the sample reported adequate health literacy. Given that only
hypertension medication adherence was measured, it would be beneficial to explore all
medication adherence in persons with MetS. Further study is warranted.
Barriers
Complexity of the medication regimen
Research suggests that factors associated with medication non-adherence appear
to be the complexity of the medication regimen, the degree of medication supervision,
monitoring by healthcare providers, health status of the patient, and available social
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support (Murray et al., 2004; Safeer & Keenan, 2005). Previous research has shown that
better medication adherence is associated with single dosing while multiple dosing
frequently leads to non-adherence (Hilgers & Mann, 2008; Safeer & Keenan, 2005;
Wright et al., 2008). Consistent with this finding, in the current study, 25% (n=23) of the
sample was on multiple dosing regimens, and more than a quarter (n=27) of the sample
was non-adherent with their regimens. Conversely, in the current study, the majority
(70%) of the study participants were on single dosing regimens, and most of the
participants (n=64; 70%) were adherent.
Similarly, in a study by Safeer and Keenan (2005) the sample on simple
medication regimens reported more medication adherence. It is notable that although the
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure: The JNC-7 Report (JNC7) (Chobanian et al.,
2003) recommends combination therapy as the first line of defense in controlling BP,
almost 70% of the participants were on monotherapy. It is therefore not surprising that
half of the sample presented with uncontrolled BP (>130/90 mmHg) despite being on
antihypertensive medication regimens.
Health Care Climate
The literature showed that barriers to MA include personal and institutional
barriers. Absence of a healthy therapeutic relationship between the physician and the
patient due to lack of trust or lack of culturally sensitive care may influence MA.
Institutional barriers such as discrimination and prejudice may prevent older adults from
receiving adequate information or even preclude involvement in their healthcare decision
making. If there is no satisfaction with the healthcare climate, or if the healthcare
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environment precludes autonomy, individuals may not feel accountable and may deviate
from the medication regimen (Chiriboga et al., 2005, Williams et al., 1998). Moreover, it
is well documented that open communication is a critical component of the healthcare
climate (Friedman et al., 2008; Veazie & Cai, 2007).
In the current study, the median health care climate score was 5.5 (range 4.5 6.0) which indicated that majority of the sample (94%) reported autonomy and
satisfaction with the therapeutic relationship. However, it is not clear how well this
autonomy or satisfaction with the healthcare provider translates to involvement in the
healthcare, or how effective the health communication is between the participants and
their healthcare providers. For example, although more than a half (n=48) had fasting
blood glucose levels above 100 mg/dl, only three participants were diagnosed with
impaired fasting glucose. Last, although the majority of the sample (n=86; 94%) reported
a feeling of autonomy or satisfaction with the therapeutic relationship, there was no
significant relationship between healthcare climate and MA.
Environmental Factors
Stress
Empiric evidence suggests that environmental demands predispose individuals to
psychological stress (Berkman et al., 2003; Cohen, Kamarck, & Mermelstein, 1983;
Steptoe et al., 2008; Williams, 1998). In addition, the availability of healthcare
management resources impact stress, which frequently leads to negative health outcomes
(Williams, 1998). Knox and colleagues (2008) posited that depression in AAs is very
prevalent due to a convergence of societal and biological factors including obesity,
anxiety, anger and resultant morbidity related to stress. Stress may be caused by racial
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discrimination and institutionalized racism in healthcare or in the workplace (Williams,
1998). Empiric evidence showed that stress was linked to depression which frequently
resulted in low medication adherence (Berkman et al., 2003; Cohen et al., 1983). Health
disparities may be related to the socio-demographic and cultural factors of stress
exposure including financial strain and variations in adaptive resources, inadequate social
support systems, and the stigma of mental health such as depression (Chiroboga et al.,
2005; Williams, 1998). Findings from the current study showed that the majority of the
sample (94%) had low stress.
In the current study, there was a trend toward improved medication adherence with
lower stress scores, Cohen et al. (2006) found that individuals who reported low stress
were more likely to engage in health-seeking behaviors and appeared more
knowledgeable about their health problems, and displayed more medication nonadherence. In previous research individuals who were categorized as having high stress
(PSS score greater than or equal to 20), were less likely to engage in health behaviors and
were less knowledgeable about their health problems (Cohen et al., 2006).
Social Support
The literature shows the protective effects of social support for positive healthcare
outcomes and health behaviors (Collie, Wong, Tiltson et al, 2005; Lee & Sharpe, 2007;).
Therefore, social support is an important factor in chronic illness management (Haslam,
Pakenam, & Smith (2006). In the current study, almost one half of the participants were
married, and less than a quarter were single. However, it was not clear what percentage
of the remaining participants were living with significant others. Notwithstanding, the
sample reported adequate available social support (mean score of 26, out of a possible
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34), which is an important explanatory variable of high medication adherence.
Consistent with the literature (Gallant et al, 2003; Vaglio et al., 2004), there was a
significant relationship between social support and medication adherence in the current
sample. Adequate social support has been linked to access to resources that help solve
problems thus leading to confidence, personal control of chronic illness, increased selfmanagement behavior , and general control over life (Baker et al., 2002; Lucove,
Kaufman, & James, 2007). These authors concluded that when stressors are experienced,
having enough social capital increases likelihood that stressors will be handled
appropriately.
Limitations
Although this research will add to the limited literature concerning middle-aged
African Americans’ non-adherence with medical regimens, this research is still
preliminary and has several limitations. First, a threat to external validity was that the
sample was a convenience sample of self-reported MetS patients whose medicationtaking behavior may not be representative of the general population. Because this study
sample was a convenience sample, the unknown unique characteristics of volunteers was
a limiting factor in this study. Moreover, the sample was a homogenous sample from a
larger convenience sample, which may bias the findings. The sample was not
representative of a typical AA population experiencing health disparities. These
participants were primarily middle-aged African Americans; therefore the findings may
not be generalizeable to other races or persons in different age categories.
Because the study was based on self-reports, medication adherence may have been
over- or under-reported. For example, over half (n=46) of the participants presented with
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elevated BP despite being on anti-hypertensive medications, suggesting their BP was
uncontrolled. The instruments for measuring HL and MA were not objective. More
objective measures such as pill counts or Medication Electronic Monitoring (MEM)
would give more accurate reports of medication adherence (Balkrishnan et al., 2004).
Lastly this cross-sectional study only analyzed baseline data so did not capture change
over time.
Despite these limitations, study findings may provide a deeper understanding of the
relationship among personal characteristics, environmental factors, and medication
adherence in African Americans. The study is important because the results showed that
low MA was a fairly frequent occurrence with adults, especially those with chronic
illnesses such as MetS. Since African Americans experience huge disparities with
chronic illnesses, particularly early onset of cardiovascular diseases and diabetes
(Henderson et al., 2007; Safeer & Keenan, 2005; Sorrell, 2004); interventions may be
implemented to improve medication adherence in AA with MetS. These interventions
would lead to more positive healthcare outcomes for AA adults.
Implications for Health Practices
The study has several implications for nursing practice and patient outcomes. First,
more collaboration is needed so that at each stage of the health delivery process,
healthcare professionals assume advocacy roles for each patient. A therapeutic
healthcare climate and health information provided at the appropriate level will lead to
greater medication adherence and improved healthcare outcomes (Friedman et al., 2008;
Praska et al., 2005). A therapeutic HCC will be created when AA adults are given the
opportunity to discuss their concerns and to have meaningful discussion with their
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heathcare providers, rather than being passively involved in their healthcare decisions.
Clinicians need to spend more time answering questions and have patients return
demonstrate that they understand their medical instructions. According to Kripalani et al.
(2006) patients complained that they felt rushed by their doctors and they complained
that they were not fully instructed on new medications use, side effects or indications. In
fact, these many patients reported excessive re-hospitalizations due to inappropriate
medication dosing (Toren et al., 2005). It is well established that simpler regimens will
lead to more effective outcomes (Lagu et al., 2009). Moreover, the healthcare delivery
system needs to be improved so that a collective effort is made to provide qualified
advice, in order for patients to receive sufficient information about their own drug
therapy. Research suggests that a more individualized versus generalized approach in
medication administration for AA adults is needed (Toren et al., 2005).
The current study provided evidence that adequate health literacy, available social
support, and satisfaction with the healthcare climate may influence medication adherence.
When adults can afford their medications, have adequate health insurance, supportive
social networks, and autonomy support from their HCC, they will be more likely to take
charge of their health. Hixon (2004) and Gazmararian et al. (2003) found that inadequate
health literacy may lead to medication non-adherence because adults may have problems
accessing healthcare, following medication instructions, and remembering to take their
medications. If patients do not know that “three times a day” means every eight hours
they will take their HTN medications at arbitrary times, and never achieve therapeutic
effectiveness. Educational attainment is not always the best assessment of readiness to
understand health information. Health care providers should not assume that having a
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college education automatically makes one ready to understand health information.
Although 95% of the sample read at high school level or greater, only 70% reported
adequate HTN medication adherence. Results from this current study suggest that there
is a dynamic interplay of general literacy, health literacy, and medication adherence. The
participants in the current study were well educated, reported good income and were
more likely to adhere to their medication regimen. It is also well established that poor
health communication or ineffective interaction with the healthcare provider is associated
with low medication adherence (Friedman et al., 2008). The findings for the current
study are inconclusive because the overwhelming majority (94%) of the sample reported
satisfaction with their healthcare climate, yet there was no significant relationship was
found between medication adherence and healthcare climate. Currently, a critical need
exists for research such as this to identify patients at risk for inadequate health literacy
and low hypertension medication adherence, and to intervene early to predict more
positive healthcare outcomes.
Implications for Future Research
Future research could use longitudinal design to capture hypertension MA behavior
change over time. In addition, future research could examine hypertension medication
non-adherence from a gender perspective because the literature suggests that AA women
have approximately 57% higher prevalence of MetS than their male counterparts (25%
versus 16%) (Appel et al., 2006; Clark & El-Etat, 2007; Ford, 2006).
Although 69% of the sample attained a college education, 95% of the sample read at
high school reading level or greater. More objective methods of eliciting and measuring
health literacy would be meaningful. For example, although more expensive, the Test of
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Functional Health Literacy in Adults (TOFHLA) and the Medication Event Monitoring
caps would be more objective instruments for assessing both reading recognition and
understanding both written and numeric health information in a way that allows AAs to
take charge of their health care. Lastly, future research could be conducted with welleducated AAs versus less educated AAs with MetS to describe the differences.
Comparison of Findings to SCT Framework
Conceptually, using the SCT framework, the key study variables should predict
medication adherence in the cohort of AA adults with MetS. The SCT was useful for this
cohort of AA adults with MetS. The participants’ personal characteristics displayed a
triadic reciprocality with the environmental factors, and behavioral capability. For
example, the participants were well-educated, reported good income, low stress,
relatively low depression, adequate social support and behavioral capability (high health
literacy), and several co-morbidities. Barriers with medication adherence were minimal
since the overwhelming majority of the participants reported simple medication regimens
and high satisfaction with their healthcare climate. However, many of the key variables
were not significantly associated with medication adherence, moreover it was not
meaningful to do further comparisons related to health literacy and gender due to a lack
of variability.
Notably, consistent with the SCT, the study findings suggested that changes in one
construct (personal characteristics) appeared to influence other constructs such as
behavioral capability and environmental factors. For example, higher education was
significantly associated with better health literacy; higher income was significantly
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associated with low stress; while adequate social support was significantly associated
with low stress, low depression, and high health literacy.
The association of barriers to expected outcomes was consistent with the framework.
Consistent with the literature, these AA adults with MetS were mostly on simple
regimens and reported good hypertension medication adherence (Poon et al, 2009). In
addition, the participants reported high satisfaction with their healthcare climate and
would be expected to report good medication adherence (Williams et al., 2005).
However, the relationship between healthcare climate, complexity of regimen, and
hypertension medication adherence was not significant so the research question was not
answered. Although the majority of the participants reported high satisfaction with their
healthcare providers, it was not clear to what degree satisfaction with the healthcare
climate influenced medication taking behavior. Further study is needed to explore the
mediating pathways between personal characteristics, environmental factors, behavioral
capability, barriers, and hypertension medication adherence.
Conclusion
Data were collected from 91 participants as part of a larger intervention study to
reduce CVD disparities in minorities. The purpose of this study was to examine
medication adherence in AA adults with MetS by determining the relationships among
personal characteristics, behavioral capability, and environmental factors. Personal
characteristics included age, gender, income, and education; behavioral capability was
conceptualized as health literacy, while environmental factors included stress, depression,
social support, and barriers included complexity of the medication regimen, and quality
of the therapeutic relationship. Research suggests that AA adults are more likely to have
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inadequate functional health literacy than younger adults. However, in the current study,
most of the older participants reported adequate health literacy. Moreover, it is welldocumented that a significant relationship exists among medication adherence and key
study variables in a variety of clinical populations. In fact, in study populations such as
cancer, high blood pressure, renal populations, and diabetic populations, researchers
provided evidence that key study variables positively influenced medication adherence
(Rothman et al., 2005; Bosworth et al., 2006; Schillinger et al., 2006). Surprisingly, in
the current study, an investigation of key study variables did not yield similar findings to
those unearthed in other study populations.
Given that the research questions were only partially answered, further research is
warranted to more clearly define the suspected relationships using more objective
measures to assess medication adherence and possibly to include another measure such
as the Test of Functional Health Literacy in Adults (TOFHLA) which captures reading
comprehension, not just reading recognition as demonstrated in the REALM. These
findings suggest that further investigation of the relationships and potential mediating
pathways between personal characteristics, environmental factors, and behavioral
capability that may contribute to hypertension medication non-adherence in African
American adults with MetS is needed.
Although current sample was homogenous in both personal and environmental
factors and not representative of a typical AA cohort with MetS, study findings were
consistent with the literature. The study results provided evidence that AA adults are still
receiving inappropriate medication regimens for their chronic illnesses. It is therefore not
surprising that although CVD morbidity and mortality have decreased over the last
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decade, the incidences of CVD morbidity and mortality for AAs continue to rise. Health
care providers continue to disregard the recommendations of the JNC7 for combating
uncontrolled high blood pressure in AAs. Disparities in diagnoses and treatment need to
be more adequately addressed. For example, health care providers and insurance
companies need to be held more accountable for inadequate treatment of chronic illnesses
in AAs. African American adults must be more actively involved in decisions regarding
their care, by being more educated to ask good questions and not being afraid to talk with
their healthcare providers. It was very surprising that 70% of the current sample was on
monotherapy. Unless drastic changes are implemented in the way AAs receive care for
their chronic illnesses, AA s will continue to have worse healthcare outcomes than any
other group.
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Rapid Estimate of Adult Literacy in Medicine (REALM)
Rapid Estimate of Adult Literacy in Medicine
Patient name ___________________ Date of birth__________________ Reading level__________
List 1

List 2

List 3

Fat

Fatigue

Allergic

Flu

Pelvic

Menstrual

Pill

Jaundice

Testicle

Dose

Infection

Colitis

Eye

Exercise

Emergency

Stress

Behavior

Medication

Smear

Prescription

Occupation

Nerves

Notify

Sexuality

Germs

Gallbladder

Alcoholism

Meals

Calories

Irritation

Disease

Depression

Constipation

Cancer

Miscarriage

Gonorrhea

Caffeine

Pregnancy

Inflammatory

Attack

Arthritis

Diabetes

Kidney

Nutrition

Hepatitis

Hormones

Menopause

Antibiotics

Herpes

Appendix

Diagnosis

Seizure

Abnormal

Potassium

Bowel

Syphilis

Anemia
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Asthma

Hemorrhoids

Obesity

Rectal

Nausea

Osteoporosis

Incest

Directed

Impetigo

List 1 score

_________

List 2 score

_________

List 3 score

_________
Raw score___________
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